{"id":12078,"date":"2015-01-18T18:00:42","date_gmt":"2015-01-18T11:00:42","guid":{"rendered":"https:\/\/luatsubaoho.com\/phapluat\/?p=12078"},"modified":"2024-04-05T17:12:11","modified_gmt":"2024-04-05T10:12:11","slug":"nghi-dinh-73-2018-nd-cp-quy-dinh-ve-danh-muc-chat-ma-tuy-va-tien-chat-ma-tuy","status":"publish","type":"post","link":"https:\/\/luatsubaoho.com\/phapluat\/nghi-dinh-73-2018-nd-cp-quy-dinh-ve-danh-muc-chat-ma-tuy-va-tien-chat-ma-tuy\/","title":{"rendered":"Ngh\u1ecb \u0111\u1ecbnh 73\/2018\/N\u0110-CP quy \u0111\u1ecbnh v\u1ec1 danh m\u1ee5c ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t ma t\u00fay"},"content":{"rendered":"\n

Ngh\u1ecb \u0111\u1ecbnh 73\/2018\/N\u0110-CP quy \u0111\u1ecbnh v\u1ec1 danh m\u1ee5c ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t ma t\u00fay<\/p>\n\n\n\n\n
\n

CH\u00cdNH PH\u1ee6
<\/b><\/p>\n<\/td>\n

\n

C\u1ed8NG H\u00d2A X\u00c3 H\u1ed8I CH\u1ee6 NGH\u0128A VI\u1ec6T NAM
\u0110\u1ed9c l\u1eadp \u2013 T\u1ef1 do \u2013 H\u1ea1nh ph\u00fac\u00a0
<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

S\u1ed1: 73\/2018\/N\u0110-CP<\/p>\n<\/td>\n

\n

H\u00e0 N\u1ed9i, ng\u00e0y 15 th\u00e1ng 5 n\u0103m 2018<\/i><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u0110\u00e3 c\u00f3 \u00bb Ngh\u1ecb \u0111\u1ecbnh s\u1ed1\u00a057\/2022\/N\u0110-CP\u00a0Quy \u0111\u1ecbnh c\u00e1c danh m\u1ee5c ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t<\/a><\/p>\n

NGH\u1eca \u0110\u1ecaNH<\/span><\/b><\/p>\n

QUY \u0110\u1ecaNH C\u00c1C DANH M\u1ee4C CH\u1ea4T MA T\u00daY V\u00c0 TI\u1ec0N CH\u1ea4T<\/p>\n

C\u0103n c\u1ee9 Lu\u1eadt t\u1ed5 ch\u1ee9c Ch\u00ednh ph\u1ee7 ng\u00e0y 19 th\u00e1ng 6 n\u0103m 2015;
<\/i>C\u0103n c\u1ee9 Lu\u1eadt ph\u00f2ng, ch\u1ed1ng ma t\u00fay ng\u00e0y 09 th\u00e1ng 12 n\u0103m 2000 v\u00e0 Lu\u1eadt s\u1eeda \u0111\u1ed5i, b\u1ed5 sung m\u1ed9t s\u1ed1 \u0110i\u1ec1u c\u1ee7a Lu\u1eadt ph\u00f2ng, ch\u1ed1ng ma t\u00fay ng\u00e0y 03 th\u00e1ng 6 n\u0103m 2008;
<\/i>C\u0103n c\u1ee9 Lu\u1eadt s\u1eeda \u0111\u1ed5i, b\u1ed5 sung m\u1ed9t s\u1ed1 \u0110i\u1ec1u c\u1ee7a B\u1ed9 lu\u1eadt H\u00ecnh s\u1ef1 ng\u00e0y 20 th\u00e1ng 6 n\u0103m 2017;
<\/i>C\u0103n c\u1ee9 Lu\u1eadt h\u00f3a ch\u1ea5t ng\u00e0y 21 th\u00e1ng 11 n\u0103m 2007;
<\/i>C\u0103n c\u1ee9 Lu\u1eadt d\u01b0\u1ee3c ng\u00e0y 06 th\u00e1ng 4 n\u0103m 2016;
<\/i>Theo \u0111\u1ec1 ngh\u1ecb c\u1ee7a B\u1ed9 tr\u01b0\u1edfng B\u1ed9 C\u00f4ng an;
<\/i>Ch\u00ednh ph\u1ee7 ban h\u00e0nh Ngh\u1ecb \u0111\u1ecbnh quy \u0111\u1ecbnh c\u00e1c danh M\u1ee5c ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t.<\/i><\/p>\n

\u0110i\u1ec1u 1. Danh M\u1ee5c c\u00e1c ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t<\/b><\/p>\n

Ban h\u00e0nh k\u00e8m theo Ngh\u1ecb \u0111\u1ecbnh n\u00e0y c\u00e1c danh M\u1ee5c ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t sau \u0111\u00e2y:<\/p>\n

Danh M\u1ee5c I: C\u00e1c ch\u1ea5t ma t\u00fay tuy\u1ec7t \u0111\u1ed1i c\u1ea5m s\u1eed d\u1ee5ng trong y h\u1ecdc v\u00e0 \u0111\u1eddi s\u1ed1ng x\u00e3 h\u1ed9i; vi\u1ec7c s\u1eed d\u1ee5ng c\u00e1c ch\u1ea5t n\u00e0y trong ph\u00e2n t\u00edch, ki\u1ec3m nghi\u1ec7m, nghi\u00ean c\u1ee9u khoa h\u1ecdc, \u0110i\u1ec1u tra t\u1ed9i ph\u1ea1m theo quy \u0111\u1ecbnh \u0111\u1eb7c bi\u1ec7t c\u1ee7a c\u01a1 quan c\u00f3 th\u1ea9m quy\u1ec1n.<\/p>\n

Danh M\u1ee5c II: C\u00e1c ch\u1ea5t ma t\u00fay \u0111\u01b0\u1ee3c d\u00f9ng h\u1ea1n ch\u1ebf trong ph\u00e2n t\u00edch, ki\u1ec3m nghi\u1ec7m, nghi\u00ean c\u1ee9u khoa h\u1ecdc, \u0110i\u1ec1u tra t\u1ed9i ph\u1ea1m ho\u1eb7c trong l\u0129nh v\u1ef1c y t\u1ebf theo quy \u0111\u1ecbnh c\u1ee7a c\u01a1 quan c\u00f3 th\u1ea9m quy\u1ec1n.<\/p>\n

Danh M\u1ee5c III: C\u00e1c ch\u1ea5t ma t\u00fay \u0111\u01b0\u1ee3c d\u00f9ng trong ph\u00e2n t\u00edch, ki\u1ec3m nghi\u1ec7m, nghi\u00ean c\u1ee9u khoa h\u1ecdc, \u0110i\u1ec1u tra t\u1ed9i ph\u1ea1m ho\u1eb7c trong l\u0129nh v\u1ef1c y t\u1ebf, th\u00fa y theo quy \u0111\u1ecbnh c\u1ee7a c\u01a1 quan c\u00f3 th\u1ea9m quy\u1ec1n.<\/p>\n

Danh M\u1ee5c IV: C\u00e1c ti\u1ec1n ch\u1ea5t.<\/p>\n

C\u00e1c ti\u1ec1n ch\u1ea5t s\u1eed d\u1ee5ng v\u00ec M\u1ee5c \u0111\u00edch qu\u1ed1c ph\u00f2ng, an ninh do B\u1ed9 C\u00f4ng an qu\u1ea3n l\u00fd v\u00e0 c\u1ea5p ph\u00e9p xu\u1ea5t kh\u1ea9u, nh\u1eadp kh\u1ea9u. C\u00e1c ti\u1ec1n ch\u1ea5t s\u1eed d\u1ee5ng trong l\u0129nh v\u1ef1c th\u00fa y do B\u1ed9 N\u00f4ng nghi\u1ec7p v\u00e0 Ph\u00e1t tri\u1ec3n n\u00f4ng th\u00f4n qu\u1ea3n l\u00fd v\u00e0 c\u1ea5p ph\u00e9p xu\u1ea5t kh\u1ea9u, nh\u1eadp kh\u1ea9u.<\/p>\n

\u0110i\u1ec1u 2. Hi\u1ec7u l\u1ef1c thi h\u00e0nh<\/b><\/p>\n

1. Ngh\u1ecb \u0111\u1ecbnh n\u00e0y c\u00f3 hi\u1ec7u l\u1ef1c thi h\u00e0nh k\u1ec3 t\u1eeb ng\u00e0y k\u00fd ban h\u00e0nh.<\/p>\n

2. Ngh\u1ecb \u0111\u1ecbnh s\u1ed1 82\/2013\/N\u0110-CP ng\u00e0y 19 th\u00e1ng 7 n\u0103m 2013 c\u1ee7a Ch\u00ednh ph\u1ee7 ban h\u00e0nh c\u00e1c danh M\u1ee5c ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t v\u00e0 Ngh\u1ecb \u0111\u1ecbnh s\u1ed1 126\/2015\/N\u0110-CP ng\u00e0y 09 th\u00e1ng 12 n\u0103m 2015 c\u1ee7a Ch\u00ednh ph\u1ee7 s\u1eeda \u0111\u1ed5i, b\u1ed5 sung danh M\u1ee5c c\u00e1c ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t ban h\u00e0nh k\u00e8m theo Ngh\u1ecb \u0111\u1ecbnh s\u1ed1 82\/2013\/N\u0110-CP ng\u00e0y 19 th\u00e1ng 7 n\u0103m 2013 c\u1ee7a Ch\u00ednh ph\u1ee7 ban h\u00e0nh c\u00e1c danh M\u1ee5c ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t h\u1ebft hi\u1ec7u l\u1ef1c k\u1ec3 t\u1eeb ng\u00e0y Ngh\u1ecb \u0111\u1ecbnh n\u00e0y c\u00f3 hi\u1ec7u l\u1ef1c.<\/p>\n

3. C\u00e1c t\u1ed5 ch\u1ee9c, c\u00e1 nh\u00e2n kinh doanh hai ti\u1ec1n ch\u1ea5t N-Phenethyl-4-piperidinone (NPP) v\u00e0 4-ANPP th\u1ef1c hi\u1ec7n c\u00e1c quy \u0111\u1ecbnh v\u1ec1 qu\u1ea3n l\u00fd ti\u1ec1n ch\u1ea5t theo Ngh\u1ecb \u0111\u1ecbnh n\u00e0y v\u00e0 c\u00e1c v\u0103n b\u1ea3n c\u00f3 li\u00ean quan k\u1ec3 t\u1eeb ng\u00e0y 01 th\u00e1ng 7 n\u0103m 2018.<\/p>\n

\u0110i\u1ec1u 3. T\u1ed5 ch\u1ee9c th\u1ef1c hi\u1ec7n<\/b><\/p>\n

1. C\u00e1c B\u1ed9 tr\u01b0\u1edfng, Th\u1ee7 tr\u01b0\u1edfng c\u01a1 quan ngang b\u1ed9, Th\u1ee7 tr\u01b0\u1edfng c\u01a1 quan thu\u1ed9c Ch\u00ednh ph\u1ee7, Ch\u1ee7 t\u1ecbch \u1ee6y ban nh\u00e2n d\u00e2n c\u00e1c t\u1ec9nh, th\u00e0nh ph\u1ed1 tr\u1ef1c thu\u1ed9c trung \u01b0\u01a1ng ch\u1ecbu tr\u00e1ch nhi\u1ec7m thi h\u00e0nh Ngh\u1ecb \u0111\u1ecbnh n\u00e0y.<\/p>\n

2. B\u1ed9 N\u00f4ng nghi\u1ec7p v\u00e0 Ph\u00e1t tri\u1ec3n n\u00f4ng th\u00f4n c\u00f3 tr\u00e1ch nhi\u1ec7m qu\u1ea3n l\u00fd c\u00e1c thu\u1ed1c th\u00fa y c\u00f3 ch\u1ee9a ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t theo quy \u0111\u1ecbnh t\u1ea1i Ngh\u1ecb \u0111\u1ecbnh s\u1ed1 58\/2003\/N\u0110-CP ng\u00e0y 29 th\u00e1ng 5 n\u0103m 2003 c\u1ee7a Ch\u00ednh ph\u1ee7 quy \u0111\u1ecbnh v\u1ec1 ki\u1ec3m so\u00e1t nh\u1eadp kh\u1ea9u, xu\u1ea5t kh\u1ea9u, v\u1eadn chuy\u1ec3n qu\u00e1 c\u1ea3nh l\u00e3nh th\u1ed5 Vi\u1ec7t Nam ch\u1ea5t ma t\u00fay, ti\u1ec1n ch\u1ea5t, thu\u1ed1c g\u00e2y nghi\u1ec7n, thu\u1ed1c h\u01b0\u1edbng th\u1ea7n v\u00e0 Ngh\u1ecb \u0111\u1ecbnh s\u1ed1 80\/2001\/N\u0110-CP ng\u00e0y 05 th\u00e1ng 11 n\u0103m 2001 c\u1ee7a Ch\u00ednh ph\u1ee7 h\u01b0\u1edbng d\u1eabn vi\u1ec7c ki\u1ec3m so\u00e1t c\u00e1c ho\u1ea1t \u0111\u1ed9ng h\u1ee3p ph\u00e1p li\u00ean quan \u0111\u1ebfn ma t\u00fay \u1edf trong n\u01b0\u1edbc.<\/p>\n

3. Khi ph\u00e1t hi\u1ec7n ch\u1ea5t m\u1edbi ch\u01b0a c\u00f3 trong c\u00e1c danh M\u1ee5c ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t ban h\u00e0nh k\u00e8m theo Ngh\u1ecb \u0111\u1ecbnh n\u00e0y li\u00ean quan \u0111\u1ebfn vi\u1ec7c s\u1ea3n xu\u1ea5t, \u0110i\u1ec1u ch\u1ebf, s\u1eed d\u1ee5ng ch\u1ea5t ma t\u00fay ho\u1eb7c theo quy \u0111\u1ecbnh t\u1ea1i 03 C\u00f4ng \u01b0\u1edbc c\u1ee7a Li\u00ean h\u1ee3p qu\u1ed1c v\u1ec1 ph\u00f2ng, ch\u1ed1ng ma t\u00fay th\u00ec B\u1ed9 C\u00f4ng an c\u00f3 tr\u00e1ch nhi\u1ec7m ch\u1ee7 tr\u00ec, ph\u1ed1i h\u1ee3p v\u1edbi B\u1ed9 Y t\u1ebf, B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng, B\u1ed9 Khoa h\u1ecdc v\u00e0 C\u00f4ng ngh\u1ec7, B\u1ed9 N\u00f4ng nghi\u1ec7p v\u00e0 Ph\u00e1t tri\u1ec3n n\u00f4ng th\u00f4n v\u00e0 c\u00e1c c\u01a1 quan c\u00f3 li\u00ean quan xem x\u00e9t, tr\u00ecnh Ch\u00ednh ph\u1ee7 s\u1eeda \u0111\u1ed5i, b\u1ed5 sung v\u00e0 c\u00f4ng b\u1ed1 c\u00e1c danh M\u1ee5c \u0111\u00f3.\/.<\/p>\n\n\n\n
\n

N\u01a1i nh\u1eadn:
<\/i><\/b>\u2013 Ban B\u00ed th\u01b0 Trung \u01b0\u01a1ng \u0110\u1ea3ng;
\u2013 Th\u1ee7 t\u01b0\u1edbng, c\u00e1c Ph\u00f3 Th\u1ee7 t\u01b0\u1edbng Ch\u00ednh ph\u1ee7;
\u2013 C\u00e1c b\u1ed9, c\u01a1 quan ngang b\u1ed9, c\u01a1 quan thu\u1ed9c Ch\u00ednh ph\u1ee7;
\u2013 H\u0110ND, UBND c\u00e1c t\u1ec9nh, th\u00e0nh ph\u1ed1 tr\u1ef1c thu\u1ed9c trung \u01b0\u01a1ng;
\u2013 V\u0103n ph\u00f2ng Trung \u01b0\u01a1ng v\u00e0 c\u00e1c Ban c\u1ee7a \u0110\u1ea3ng;
\u2013 V\u0103n ph\u00f2ng T\u1ed5ng B\u00ed th\u01b0;
\u2013 V\u0103n ph\u00f2ng Ch\u1ee7 t\u1ecbch n\u01b0\u1edbc;
\u2013 H\u1ed9i \u0111\u1ed3ng d\u00e2n t\u1ed9c v\u00e0 c\u00e1c \u1ee6y ban c\u1ee7a Qu\u1ed1c h\u1ed9i;
\u2013 V\u0103n ph\u00f2ng Qu\u1ed1c h\u1ed9i;
\u2013 T\u00f2a \u00e1n nh\u00e2n d\u00e2n t\u1ed1i cao;
\u2013 Vi\u1ec7n ki\u1ec3m s\u00e1t nh\u00e2n d\u00e2n t\u1ed1i cao;
\u2013 Ki\u1ec3m to\u00e1n nh\u00e0 n\u01b0\u1edbc;
\u2013 \u1ee6y ban Gi\u00e1m s\u00e1t t\u00e0i ch\u00ednh Qu\u1ed1c gia;
\u2013 Ng\u00e2n h\u00e0ng Ch\u00ednh s\u00e1ch x\u00e3 h\u1ed9i;
\u2013 Ng\u00e2n h\u00e0ng Ph\u00e1t tri\u1ec3n Vi\u1ec7t Nam;
\u2013 \u1ee6y ban trung \u01b0\u01a1ng M\u1eb7t tr\u1eadn T\u1ed5 qu\u1ed1c Vi\u1ec7t Nam;
\u2013 C\u01a1 quan trung \u01b0\u01a1ng c\u1ee7a c\u00e1c \u0111o\u00e0n th\u1ec3;
\u2013 VPCP: BTCN, c\u00e1c PCN, Tr\u1ee3 l\u00fd TTg, TG\u0110 C\u1ed5ng TT\u0110T, c\u00e1c V\u1ee5, C\u1ee5c, \u0111\u01a1n v\u1ecb tr\u1ef1c thu\u1ed9c, C\u00f4ng b\u00e1o;
\u2013 L\u01b0u: VT, KGVX (2). <\/span>XH<\/span><\/p>\n<\/td>\n

\n

TM. CH\u00cdNH PH\u1ee6
TH\u1ee6 T\u01af\u1edaNG

Nguy\u1ec5n X<\/b><\/p>\n

u\u00e2n <\/b><\/p>\n

Ph\u00fac<\/b><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00bb Quy \u0111\u1ecbnh vi\u1ec7c gi\u00e1m \u0111\u1ecbnh ch\u1ea5t ma t\u00fay<\/a><\/p>\n

\u00bb T\u01b0 v\u1ea5n t\u1ed9i Ma t\u00fay <\/a><\/p>\n

<\/a>DANH M\u1ee4C I<\/span><\/b><\/p>\n

<\/a>C\u00c1C CH\u1ea4T MA T\u00daY TUY\u1ec6T \u0110\u1ed0I C\u1ea4M S\u1eec D\u1ee4NG TRONG Y H\u1eccC V\u00c0 \u0110\u1edcI S\u1ed0NG X\u00c3 H\u1ed8I; VI\u1ec6C S\u1eec D\u1ee4NG C\u00c1C CH\u1ea4T N\u00c0Y TRONG PH\u00c2N T\u00cdCH, KI\u1ec2M NGHI\u1ec6M, NGHI\u00caN C\u1ee8U KHOA H\u1eccC, \u0110I\u1ec0U TRA T\u1ed8I PH\u1ea0M THEO QUY \u0110\u1ecaNH \u0110\u1eb6C BI\u1ec6T C\u1ee6A C\u01a0 QUAN C\u00d3 TH\u1ea8M QUY\u1ec0N
(Ban h\u00e0nh k\u00e8m theo Ngh\u1ecb \u0111\u1ecbnh s\u1ed1 73\/2018\/N\u0110-CP ng\u00e0y 15 th\u00e1ng 5 n\u0103m 2018 c\u1ee7a Ch\u00ednh ph\u1ee7)<\/i><\/p>\n

IA. C\u00e1c ch\u1ea5t v\u00e0 mu\u1ed1i, \u0111\u1ed3ng ph\u00e2n, ester, ether v\u00e0 mu\u1ed1i c\u1ee7a c\u00e1c \u0111\u1ed3ng ph\u00e2n, ester, ether c\u00f3 th\u1ec3 t\u1ed3n t\u1ea1i c\u1ee7a c\u00e1c ch\u1ea5t n\u00e0y<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin CAS<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

1<\/p>\n<\/td>\n

\n

Acetorphine<\/p>\n<\/td>\n

\n

3-O<\/i>-acetyltetrahydro \u2013 7 \u2013 \u03b1 <\/i>\u2013 (<\/i>1 \u2013 hydroxyl \u2013 1 \u2013 methylbutyl) \u2013 6, 14 \u2013 endo<\/i>etheno \u2013 oripavine<\/p>\n<\/td>\n

\n

25333-77-1<\/p>\n<\/td>\n<\/tr>\n

\n

2<\/p>\n<\/td>\n

\n

Acetyl-alpha<\/i>-methylfenanyl<\/p>\n<\/td>\n

\n

N<\/i>\u2013 [1 \u2013 (\u03b1<\/i> \u2013 methylphenethyl) \u2013 4 \u2013 piperidyl] acetanilide<\/p>\n<\/td>\n

\n

101860-00-8<\/p>\n<\/td>\n<\/tr>\n

\n

3<\/p>\n<\/td>\n

\n

Alphacetylmethadol<\/p>\n<\/td>\n

\n

\u03b1<\/i> \u2013 3 \u2013 acetoxy \u2013 6 \u2013 dimethylamino \u2013 4,4 \u2013 diphenylheptane<\/p>\n<\/td>\n

\n

17199-58-5<\/p>\n<\/td>\n<\/tr>\n

\n

4<\/p>\n<\/td>\n

\n

Alpha<\/i>-methylfentanyl<\/p>\n<\/td>\n

\n

N<\/i>\u2013 [1 \u2013 (\u03b1 <\/i>\u2013 methylphenethyl) \u2013 4 \u2013 peperidyl] propionanilide<\/p>\n<\/td>\n

\n

79704-88-4<\/p>\n<\/td>\n<\/tr>\n

\n

5<\/p>\n<\/td>\n

\n

Beta<\/i>-hydroxyfentanyl<\/p>\n<\/td>\n

\n

N<\/i>\u2013 [1- ( \u03b2<\/i> \u2013 hydroxyphenethyl) \u2013 4 \u2013 peperidyl] propionanilide<\/p>\n<\/td>\n

\n

78995-10-5<\/p>\n<\/td>\n<\/tr>\n

\n

6<\/p>\n<\/td>\n

\n

Beta<\/i>-hydroxymethyl-3-fentanyl<\/p>\n<\/td>\n

\n

N<\/i>\u2013 [1 \u2013 (\u03b2<\/i> \u2013 hydroxyphenethyl) \u2013 3 \u2013 methyl \u2013 4 \u2013 piperidyl] propinonanilide<\/p>\n<\/td>\n

\n

78995-14-9<\/p>\n<\/td>\n<\/tr>\n

\n

7<\/p>\n<\/td>\n

\n

Desomorphine<\/p>\n<\/td>\n

\n

Dihydrodeoxymorphine<\/p>\n<\/td>\n

\n

427-00-9<\/p>\n<\/td>\n<\/tr>\n

\n

8<\/p>\n<\/td>\n

\n

Etorphine<\/p>\n<\/td>\n

\n

Tetrahydro \u2013 7\u03b1<\/i> \u2013 (1 \u2013 hydroxy \u2013 1 \u2013 methylbutyl) \u2013 6,14 \u2013 endo<\/i>etheno -oripavine<\/p>\n<\/td>\n

\n

14521-96-1<\/p>\n<\/td>\n<\/tr>\n

\n

9<\/p>\n<\/td>\n

\n

Heroine<\/p>\n<\/td>\n

\n

Diacetylmorphine<\/p>\n<\/td>\n

\n

561-27-3<\/p>\n<\/td>\n<\/tr>\n

\n

10<\/p>\n<\/td>\n

\n

Ketobemidone<\/p>\n<\/td>\n

\n

4 \u2013 meta<\/i> \u2013 hydroxyphenyl \u2013 1 \u2013 methyl \u2013 4 \u2013 propionylpiperidine<\/p>\n<\/td>\n

\n

469-79-4<\/p>\n<\/td>\n<\/tr>\n

\n

11<\/p>\n<\/td>\n

\n

3-methylfentanyl<\/p>\n<\/td>\n

\n

N<\/i>\u2013 (3 \u2013 methyl \u2013 1 \u2013 phenethyl \u2013 4 \u2013 piperidyl) propionanilide<\/p>\n<\/td>\n

\n

42045-86-3<\/p>\n<\/td>\n<\/tr>\n

\n

12<\/p>\n<\/td>\n

\n

3-methylthiofentanyl<\/p>\n<\/td>\n

\n

N<\/i>\u2013 [3 \u2013 methyl \u2013 1 [2 \u2013 (2 \u2013 thienyl) ethyl] \u2013 4 \u2013 piperidyl] propionanilide<\/p>\n<\/td>\n

\n

86052-04-2<\/p>\n<\/td>\n<\/tr>\n

\n

13<\/p>\n<\/td>\n

\n

Morphine methobromide v\u00e0 c\u00e1c ch\u1ea5t d\u1eabn xu\u1ea5t c\u1ee7a Morphine Nit\u01a1 h\u00f3a tr\u1ecb V kh\u00e1c<\/p>\n<\/td>\n

\n

(5\u03b1<\/i>,6\u03b1<\/i>) \u2013 17 \u2013 Methyl \u2013 7,8 -didehydro \u2013 4,5 \u2013 epoxymorphinan \u2013 3,6 \u2013 diol \u2013 bromomethane (1:1)<\/p>\n<\/td>\n

\n

125-23-5<\/p>\n<\/td>\n<\/tr>\n

\n

14<\/p>\n<\/td>\n

\n

Para<\/i>-fluorofentanyl<\/p>\n<\/td>\n

\n

4\u2019 \u2013 fluoro \u2013 N<\/i> \u2013 (1 \u2013 phenethyl \u2013 4 \u2013 piperidyl) propionanilide<\/p>\n<\/td>\n

\n

90736-23-5<\/p>\n<\/td>\n<\/tr>\n

\n

15<\/p>\n<\/td>\n

\n

PEPAP<\/p>\n<\/td>\n

\n

1 \u2013 phenethyl \u2013 4 \u2013 phenyl \u2013 4 \u2013 piperidinol acetate<\/p>\n<\/td>\n

\n

64-52-8<\/p>\n<\/td>\n<\/tr>\n

\n

16<\/p>\n<\/td>\n

\n

Thiofentanyl<\/p>\n<\/td>\n

\n

N<\/i> \u2013 (1 [2- (2 \u2013 thienyl) ethyl] \u2013 4 \u2013 piperidyl] \u2013 4 \u2013 propionanilide<\/p>\n<\/td>\n

\n

1165-22-6<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

IB. C\u00e1c ch\u1ea5t v\u00e0 mu\u1ed1i, \u0111\u1ed3ng ph\u00e2n c\u00f3 th\u1ec3 t\u1ed3n t\u1ea1i c\u1ee7a c\u00e1c ch\u1ea5t n\u00e0y<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin CAS<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

17<\/p>\n<\/td>\n

\n

Brolamphetamine (DOB)<\/p>\n<\/td>\n

\n

2,5 \u2013 dimethoxy \u2013 4 \u2013 bromoamphetamine<\/p>\n<\/td>\n

\n

64638-07-9<\/p>\n<\/td>\n<\/tr>\n

\n

18<\/p>\n<\/td>\n

\n

Cathinone<\/p>\n<\/td>\n

\n

(-) \u2013 \u03b1<\/i> \u2013 aminopropiophenone<\/p>\n<\/td>\n

\n

71031-15-7<\/p>\n<\/td>\n<\/tr>\n

\n

19<\/p>\n<\/td>\n

\n

DET<\/p>\n<\/td>\n

\n

N, N<\/i> \u2013 diethyltryptamine<\/p>\n<\/td>\n

\n

7558-72-7<\/p>\n<\/td>\n<\/tr>\n

\n

20<\/p>\n<\/td>\n

\n

Delta-9-tetrahydrocanabinol<\/p>\n<\/td>\n

\n

(6aR<\/i>, 10aR<\/i>) \u2013 6a<\/i>, 7, 8, 10a<\/i> \u2013 tetrahydro \u2013 6,6,9 \u2013 trimethyl \u2013 3 \u2013 pentyl \u2013 6H<\/i> \u2013 dibenzo [b,d<\/i>] pyran \u2013 1 \u2013 ol<\/p>\n<\/td>\n

\n

1972-08-3<\/p>\n<\/td>\n<\/tr>\n

\n

21<\/p>\n<\/td>\n

\n

DMA<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 2,5 \u2013 dimethoxy \u2013 \u03b1<\/i> \u2013 methylphenylethylamine<\/p>\n<\/td>\n

\n

2801-68-5<\/p>\n<\/td>\n<\/tr>\n

\n

22<\/p>\n<\/td>\n

\n

DMHP<\/p>\n<\/td>\n

\n

3 \u2013 (1,2 \u2013 dimethylheptyl) \u2013 1 \u2013 hydroxy \u2013 7, 8, 9, 10 \u2013 tetrahydro \u2013 6,6,9 \u2013 trimethyl \u2013 6H<\/i> \u2013 dibenzo [b,d<\/i>] pyran<\/p>\n<\/td>\n

\n

32904-22-6<\/p>\n<\/td>\n<\/tr>\n

\n

23<\/p>\n<\/td>\n

\n

DMT<\/p>\n<\/td>\n

\n

N, N<\/i> \u2013 dimethyltryptamine<\/p>\n<\/td>\n

\n

61-50-7<\/p>\n<\/td>\n<\/tr>\n

\n

24<\/p>\n<\/td>\n

\n

DOET<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 4 \u2013 ethyl \u2013 2,5 \u2013 dimethoxy \u2013 \u03b1 <\/i>\u2013 phenethylamine<\/p>\n<\/td>\n

\n

22004-32-6<\/p>\n<\/td>\n<\/tr>\n

\n

25<\/p>\n<\/td>\n

\n

Eticyclidine<\/p>\n<\/td>\n

\n

N<\/i>\u2013 ethyl \u2013 1 \u2013 phenylcylohexylamine<\/p>\n<\/td>\n

\n

2201-15-2<\/p>\n<\/td>\n<\/tr>\n

\n

26<\/p>\n<\/td>\n

\n

Etryptamine<\/p>\n<\/td>\n

\n

3 \u2013 (2 \u2013 aminobuty) indole<\/p>\n<\/td>\n

\n

2235-90-7<\/p>\n<\/td>\n<\/tr>\n

\n

27<\/p>\n<\/td>\n

\n

MDMA<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 N<\/i> \u2013 \u03b1<\/i> \u2013 dimethyl \u2013 3,4 \u2013 (methylenedioxy) phenethylamine<\/p>\n<\/td>\n

\n

42542-10-9<\/p>\n<\/td>\n<\/tr>\n

\n

28<\/p>\n<\/td>\n

\n

Mescalin<\/p>\n<\/td>\n

\n

3,4,5 \u2013 trimethoxyphenethylamine<\/p>\n<\/td>\n

\n

54-04-6<\/p>\n<\/td>\n<\/tr>\n

\n

29<\/p>\n<\/td>\n

\n

Methcathinone<\/p>\n<\/td>\n

\n

2 \u2013 (methylamino) \u2013 1 \u2013 phenylpropan \u2013 1 \u2013 one<\/p>\n<\/td>\n

\n

5650-44-2<\/p>\n<\/td>\n<\/tr>\n

\n

30<\/p>\n<\/td>\n

\n

4-methylaminorex<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 cis <\/i>\u2013 2 \u2013 amino \u2013 4 \u2013 methyl \u2013 5 \u2013 phenyl \u2013 2 \u2013 oxazoline<\/p>\n<\/td>\n

\n

3568-94-3<\/p>\n<\/td>\n<\/tr>\n

\n

31<\/p>\n<\/td>\n

\n

MMDA<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 5 \u2013 methoxy \u2013 3,4 \u2013 methylenedioxy \u2013\u00a0 \u03b1<\/i> \u2013 methylphenylethylamine<\/p>\n<\/td>\n

\n

13674-05-0<\/p>\n<\/td>\n<\/tr>\n

\n

32<\/p>\n<\/td>\n

\n

(+)-Lysergide (LSD)<\/p>\n<\/td>\n

\n

9,10 \u2013 didehydro \u2013 N, N<\/i> \u2013 diethyl \u2013 6 \u2013 methylergoline \u2013 8\u03b2 <\/i>carboxamide<\/p>\n<\/td>\n

\n

50-37-3<\/p>\n<\/td>\n<\/tr>\n

\n

33<\/p>\n<\/td>\n

\n

N<\/i>-hydroxy MDA (MDOH)<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 N<\/i> \u2013 hydroxy \u2013 [\u03b1 <\/i>\u2013 methyl \u2013 3,4 \u2013 (methylenedyoxy) phenethyl] hydroxylamine<\/p>\n<\/td>\n

\n

74698-47-8<\/p>\n<\/td>\n<\/tr>\n

\n

34<\/p>\n<\/td>\n

\n

N<\/i>-ethyl MDA<\/p>\n<\/td>\n

\n

(\u00b1) N<\/i> \u2013 ethyl \u2013 methyl \u2013 3,4 \u2013 (methylenedioxy) phenethylamine<\/p>\n<\/td>\n

\n

82801-81-8<\/p>\n<\/td>\n<\/tr>\n

\n

35<\/p>\n<\/td>\n

\n

Parahexyl<\/p>\n<\/td>\n

\n

3 \u2013 hexyl \u2013 7, 8, 9, 10 \u2013 tetrahydro \u2013 6, 6, 9 \u2013 trimethyl \u2013 6H<\/i> \u2013 dibenzo [b,d<\/i>] pyran \u2013 1 \u2013 ol<\/p>\n<\/td>\n

\n

117-51-1<\/p>\n<\/td>\n<\/tr>\n

\n

36<\/p>\n<\/td>\n

\n

PMA<\/p>\n<\/td>\n

\n

p<\/i> \u2013 methoxy \u2013 \u03b1<\/i> \u2013 methylphenethylamine<\/p>\n<\/td>\n

\n

64-13-1<\/p>\n<\/td>\n<\/tr>\n

\n

37<\/p>\n<\/td>\n

\n

Psilocine, Psilotsin<\/p>\n<\/td>\n

\n

3 \u2013 [2 \u2013 (dimetylamino) ethyl] indol \u2013 4 \u2013 ol<\/p>\n<\/td>\n

\n

520-53-6<\/p>\n<\/td>\n<\/tr>\n

\n

38<\/p>\n<\/td>\n

\n

Psilocybine<\/p>\n<\/td>\n

\n

3 \u2013 [2 \u2013 dimetylaminoethyl] indol \u2013 4 \u2013 yl dihydrogen phosphate<\/p>\n<\/td>\n

\n

520-52-5<\/p>\n<\/td>\n<\/tr>\n

\n

39<\/p>\n<\/td>\n

\n

Rolicyclidine<\/p>\n<\/td>\n

\n

1 \u2013 (1 \u2013 phenylcyclohexy) pyrrolidine<\/p>\n<\/td>\n

\n

2201-39-0<\/p>\n<\/td>\n<\/tr>\n

\n

40<\/p>\n<\/td>\n

\n

STP, DOM<\/p>\n<\/td>\n

\n

2,5 \u2013 dimethoxy \u2013 4,\u03b1<\/i> \u2013 dimethylphenethylamine<\/p>\n<\/td>\n

\n

15588-95-1<\/p>\n<\/td>\n<\/tr>\n

\n

41<\/p>\n<\/td>\n

\n

Tenamfetamine (MDA)<\/p>\n<\/td>\n

\n

\u03b1<\/i> \u2013 methyl \u2013 3,4 \u2013 (methylendioxy) phenethylamine<\/p>\n<\/td>\n

\n

4764-17-4<\/p>\n<\/td>\n<\/tr>\n

\n

42<\/p>\n<\/td>\n

\n

Tenocyclidine (TCP)<\/p>\n<\/td>\n

\n

1 \u2013 [1 \u2013 (2 \u2013 thienyl) cyclohexyl] piperidine<\/p>\n<\/td>\n

\n

21500-98-1<\/p>\n<\/td>\n<\/tr>\n

\n

43<\/p>\n<\/td>\n

\n

TMA<\/p>\n<\/td>\n

\n

(+) \u2013 3,4,5 \u2013 trimethoxy \u2013 \u03b1<\/i> \u2013 methylphenylethylamine<\/p>\n<\/td>\n

\n

1082-88-8<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

IC. C\u00e1c ch\u1ea5t v\u00e0 mu\u1ed1i c\u00f3 th\u1ec3 t\u1ed3n t\u1ea1i c\u1ee7a c\u00e1c ch\u1ea5t n\u00e0y<\/p>\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin CAS<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

44<\/p>\n<\/td>\n

\n

MPPP<\/p>\n<\/td>\n

\n

1 \u2013 methyl \u2013 4 \u2013 phenyl \u2013 4 \u2013 piperidinol propionate (ester)<\/p>\n<\/td>\n

\n

13147-09-6<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

ID. C\u00e1c ch\u1ea5t sau<\/p>\n\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin CAS<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

45<\/p>\n<\/td>\n

\n

C\u1ea7n sa v\u00e0 c\u00e1c ch\u1ebf ph\u1ea9m t\u1eeb c\u1ea7n sa<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n

\n

8063-14-7<\/p>\n<\/td>\n<\/tr>\n

\n

46<\/p>\n<\/td>\n

\n

L\u00e1 Khat<\/p>\n<\/td>\n

\n

L\u00e1 c\u00e2y Catha edulis<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/a>DANH M\u1ee4C II<\/span><\/b><\/p>\n

<\/a>C\u00c1C CH\u1ea4T MA T\u00daY \u0110\u01af\u1ee2C D\u00d9NG H\u1ea0N CH\u1ebe TRONG PH\u00c2N T\u00cdCH, KI\u1ec2M NGHI\u1ec6M, NGHI\u00caN C\u1ee8U KHOA H\u1eccC, \u0110I\u1ec0U TRA T\u1ed8I PH\u1ea0M HO\u1eb6C TRONG L\u0128NH V\u1ef0C Y T\u1ebe THEO QUY \u0110\u1ecaNH C\u1ee6A C\u01a0 QUAN C\u00d3 TH\u1ea8M QUY\u1ec0N
(Ban h\u00e0nh k\u00e8m theo Ngh\u1ecb \u0111\u1ecbnh s\u1ed1 73\/2018\/N\u0110-CP ng\u00e0y 15 th\u00e1ng 5 n\u0103m 2018 c\u1ee7a Ch\u00ednh ph\u1ee7)<\/i><\/p>\n

IIA. C\u00e1c ch\u1ea5t v\u00e0 mu\u1ed1i, \u0111\u1ed3ng ph\u00e2n, ester, ether v\u00e0 mu\u1ed1i c\u1ee7a c\u00e1c \u0111\u1ed3ng ph\u00e2n, ester, ether c\u00f3 th\u1ec3 t\u1ed3n t\u1ea1i c\u1ee7a c\u00e1c ch\u1ea5t n\u00e0y<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin CAS<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

1<\/p>\n<\/td>\n

\n

Acetylmethadol<\/p>\n<\/td>\n

\n

3 \u2013 acetoxy \u2013 6 \u2013 dimethylamino \u2013 4,4 \u2013 diphenylheptane<\/p>\n<\/td>\n

\n

509-74-0<\/p>\n<\/td>\n<\/tr>\n

\n

2<\/p>\n<\/td>\n

\n

AH 7921<\/p>\n<\/td>\n

\n

3, 4- dichloro- N-<\/i> [[1- (dimethylamino) xyclohexyl] methyl] \u2013 benzamit<\/p>\n<\/td>\n

\n

55154-30-8<\/p>\n<\/td>\n<\/tr>\n

\n

3<\/p>\n<\/td>\n

\n

Alfentanil<\/p>\n<\/td>\n

\n

N<\/i>\u2013 [1 \u2013 [2 \u2013 (4 \u2013 ethyl \u2013 4,5\u00a0\u2013 dihydro \u2013 5 \u2013 oxo \u2013 1H<\/i> \u2013 tetrazol \u2013 1 \u2013 yl) ethyl] \u2013 4 \u2013 (methoxymethyl) \u2013 4 \u2013 piperidinyl] \u2013 N<\/i> \u2013 phenylpropanamide<\/p>\n<\/td>\n

\n

71195-58-9<\/p>\n<\/td>\n<\/tr>\n

\n

4<\/p>\n<\/td>\n

\n

Allylprodine<\/p>\n<\/td>\n

\n

3 \u2013 allyl \u2013 1 \u2013 methyl \u2013 4 \u2013 phenyl \u2013 4 \u2013 propionoxypiperidine<\/p>\n<\/td>\n

\n

25384-17-2<\/p>\n<\/td>\n<\/tr>\n

\n

5<\/p>\n<\/td>\n

\n

Alphameprodine<\/p>\n<\/td>\n

\n

\u03b1 <\/i>\u2013 3 \u2013 ethyl \u2013 1 \u2013 methyl \u2013 4 \u2013 phenyl \u2013 4 \u2013 propionoxypiperidine<\/p>\n<\/td>\n

\n

468-51-9<\/p>\n<\/td>\n<\/tr>\n

\n

6<\/p>\n<\/td>\n

\n

Alphamethadol<\/p>\n<\/td>\n

\n

\u03b1<\/i> \u2013 6- dimethylamino \u2013 4,4 \u2013 diphenyl \u2013 3 \u2013 heptanol<\/p>\n<\/td>\n

\n

17199-54-1<\/p>\n<\/td>\n<\/tr>\n

\n

7<\/p>\n<\/td>\n

\n

Alphamethylthiofentanyl<\/p>\n<\/td>\n

\n

N <\/i>\u2013 [1 \u2013 [1 \u2013 methyl \u2013 2 \u2013 (2 \u2013 thienyl) ethyl] \u2013 4 \u2013 piperidyl] propionanilide<\/p>\n<\/td>\n

\n

103963-66-2<\/p>\n<\/td>\n<\/tr>\n

\n

8<\/p>\n<\/td>\n

\n

Alphaprodine<\/p>\n<\/td>\n

\n

(\u03b1<\/i> \u2013 1,3 \u2013 dimethyl \u2013 4 \u2013 phenyl \u2013 4 \u2013 propionoxypiperidine<\/p>\n<\/td>\n

\n

77-20-3<\/p>\n<\/td>\n<\/tr>\n

\n

9<\/p>\n<\/td>\n

\n

Anileridine<\/p>\n<\/td>\n

\n

1 \u2013 para<\/i> \u2013 aminophenethyl \u2013 4 \u2013 phenylpiperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

144-14-9<\/p>\n<\/td>\n<\/tr>\n

\n

10<\/p>\n<\/td>\n

\n

Benzenthidine<\/p>\n<\/td>\n

\n

1 \u2013 (2 \u2013 benzyloxyethyl) \u2013 4 \u2013 phenylpiperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

3691-78-9<\/p>\n<\/td>\n<\/tr>\n

\n

11<\/p>\n<\/td>\n

\n

Benzylmorphine<\/p>\n<\/td>\n

\n

3 \u2013 benzylmorphine<\/p>\n<\/td>\n

\n

36418-34-5<\/p>\n<\/td>\n<\/tr>\n

\n

12<\/p>\n<\/td>\n

\n

Betacetylmethadol<\/p>\n<\/td>\n

\n

\u03b2<\/i>\u2013 3 \u2013 acetoxy \u2013 6 \u2013 dimethylamino \u2013 4,4 \u2013 diphenylheptane<\/p>\n<\/td>\n

\n

17199-59-6<\/p>\n<\/td>\n<\/tr>\n

\n

13<\/p>\n<\/td>\n

\n

Betameprodine<\/p>\n<\/td>\n

\n

\u03b2<\/i>\u2013 3 \u2013 ethyl \u2013 1 \u2013 methyl \u2013 4 \u2013 phenyl \u2013 propionoxypiperidine<\/p>\n<\/td>\n

\n

468-50-8<\/p>\n<\/td>\n<\/tr>\n

\n

14<\/p>\n<\/td>\n

\n

Betamethadol<\/p>\n<\/td>\n

\n

\u03b2<\/i> \u2013 6 \u2013 dimethylamino \u2013 4,4 \u2013 diphenyl \u2013 3 \u2013 hepthanol<\/p>\n<\/td>\n

\n

17199-55-2<\/p>\n<\/td>\n<\/tr>\n

\n

15<\/p>\n<\/td>\n

\n

Betaprodine<\/p>\n<\/td>\n

\n

\u03b2<\/i> \u2013 1,3 \u2013 dimethyl \u2013 4 \u2013 phenyl \u2013 4 \u2013 propionoxypiperidine<\/p>\n<\/td>\n

\n

468-59-7<\/p>\n<\/td>\n<\/tr>\n

\n

16<\/p>\n<\/td>\n

\n

Bezitramide<\/p>\n<\/td>\n

\n

1 \u2013 (3 \u2013 cyano \u2013 3,3 \u2013 diphenylpropyl) \u2013 4 \u2013 (2 \u2013 oxo \u2013 3 \u2013 propionyl \u2013 1 \u2013 benzimidazolinyl) \u2013 piperidine<\/p>\n<\/td>\n

\n

15301-48-1<\/p>\n<\/td>\n<\/tr>\n

\n

17<\/p>\n<\/td>\n

\n

Clonitrazene<\/p>\n<\/td>\n

\n

(2 \u2013 para<\/i> \u2013 chlobenzyl) \u2013 1 \u2013 diethylaminoethyl \u2013 5 \u2013 nitrobenzimidazole<\/p>\n<\/td>\n

\n

3861-76-5<\/p>\n<\/td>\n<\/tr>\n

\n

18<\/p>\n<\/td>\n

\n

Cocaine<\/p>\n<\/td>\n

\n

Benzoyl \u2013 1 \u2013 ecgoninmethyloxime<\/p>\n<\/td>\n

\n

50-36-2<\/p>\n<\/td>\n<\/tr>\n

\n

19<\/p>\n<\/td>\n

\n

Codoxime<\/p>\n<\/td>\n

\n

Dihydrocodeinone \u2013 6 \u2013 carboxymethyloxime<\/p>\n<\/td>\n

\n

7125-76-0<\/p>\n<\/td>\n<\/tr>\n

\n

20<\/p>\n<\/td>\n

\n

Dextromoramide<\/p>\n<\/td>\n

\n

(+) \u2013 4 [2 \u2013 methyl \u2013 4 \u2013 oxo \u2013 3,3 \u2013 diphenyl \u2013 4 \u2013 (1 \u2013 pyrrolidinyl) butyl] morpholine<\/p>\n<\/td>\n

\n

357-56-2<\/p>\n<\/td>\n<\/tr>\n

\n

21<\/p>\n<\/td>\n

\n

Diampromide<\/p>\n<\/td>\n

\n

N <\/i>\u2013 [2 \u2013 (methylphenethylamino) \u2013 propyl] propionalinide<\/p>\n<\/td>\n

\n

552-25-0<\/p>\n<\/td>\n<\/tr>\n

\n

22<\/p>\n<\/td>\n

\n

Diethylthiambutene<\/p>\n<\/td>\n

\n

3 \u2013 diethylamino \u2013 1,1 \u2013 di \u2013 (2\u2019 \u2013 thienyl) \u2013 1 \u2013 butene<\/p>\n<\/td>\n

\n

86-14-6<\/p>\n<\/td>\n<\/tr>\n

\n

23<\/p>\n<\/td>\n

\n

Difenoxin<\/p>\n<\/td>\n

\n

1 \u2013 (3 \u2013 cyano \u2013 3,3 \u2013 diphenylpropyl) \u2013 4 \u2013 phenylisonipecotic acid<\/p>\n<\/td>\n

\n

28782-42-5<\/p>\n<\/td>\n<\/tr>\n

\n

24<\/p>\n<\/td>\n

\n

Dihydromorphine<\/p>\n<\/td>\n

\n

7,8 \u2013 dihydromorphine<\/p>\n<\/td>\n

\n

509-60-4<\/p>\n<\/td>\n<\/tr>\n

\n

25<\/p>\n<\/td>\n

\n

Dimenoxadol<\/p>\n<\/td>\n

\n

2 \u2013 dimethylaminoethyl \u2013 1 \u2013 ethoxy \u2013 1,1 -diphenylacetate<\/p>\n<\/td>\n

\n

509-78-4<\/p>\n<\/td>\n<\/tr>\n

\n

26<\/p>\n<\/td>\n

\n

Dimepheptanol<\/p>\n<\/td>\n

\n

6 \u2013 dimethylamino \u2013 4,4 \u2013 diphenyl \u2013 3 \u2013 hepthanol<\/p>\n<\/td>\n

\n

545-90-4<\/p>\n<\/td>\n<\/tr>\n

\n

27<\/p>\n<\/td>\n

\n

Dimethylthiambutene<\/p>\n<\/td>\n

\n

3 \u2013 dimethylamino \u2013 1,1 \u2013 di \u2013 (2\u2019 \u2013 thienyl) \u2013 1 \u2013 butene<\/p>\n<\/td>\n

\n

524-84-5<\/p>\n<\/td>\n<\/tr>\n

\n

28<\/p>\n<\/td>\n

\n

Dioxaphetyl butyrate<\/p>\n<\/td>\n

\n

Ethyl \u2013 4 \u2013 morpholino \u2013 2,2 \u2013 diphenylbutyrate<\/p>\n<\/td>\n

\n

467-86-7<\/p>\n<\/td>\n<\/tr>\n

\n

29<\/p>\n<\/td>\n

\n

Diphenoxylate<\/p>\n<\/td>\n

\n

1 \u2013 (3 \u2013 cyano \u2013 3,3 \u2013 diphenylpropyl) \u2013 4 \u2013 phenylpiperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

915-30-0<\/p>\n<\/td>\n<\/tr>\n

\n

30<\/p>\n<\/td>\n

\n

Dipipanone<\/p>\n<\/td>\n

\n

4,4 \u2013 diphenyl \u2013 6 \u2013 piperidine \u2013 3 \u2013 heptanone<\/p>\n<\/td>\n

\n

467-83-4<\/p>\n<\/td>\n<\/tr>\n

\n

31<\/p>\n<\/td>\n

\n

Drotebanol<\/p>\n<\/td>\n

\n

3,4 \u2013 dimethoxy \u2013 17 methylmorphinan \u2013 6\u03b2<\/i>, 14 \u2013 diol<\/p>\n<\/td>\n

\n

3176-03-2<\/p>\n<\/td>\n<\/tr>\n

\n

32<\/p>\n<\/td>\n

\n

Ecgonine v\u00e0 c\u00e1c d\u1eabn xu\u1ea5t c\u1ee7a n\u00f3<\/p>\n<\/td>\n

\n

(-) \u2013 3 \u2013 hydroxytropane \u2013 2 \u2013 carboxylate<\/p>\n<\/td>\n

\n

481-37-8<\/p>\n<\/td>\n<\/tr>\n

\n

33<\/p>\n<\/td>\n

\n

Ethylmethylthiambutene<\/p>\n<\/td>\n

\n

3 \u2013 ethylmethylamino \u2013 1,1 \u2013 di \u2013 (2\u2019 \u2013 thienyl) \u2013 1 \u2013 butene<\/p>\n<\/td>\n

\n

441-61-2<\/p>\n<\/td>\n<\/tr>\n

\n

34<\/p>\n<\/td>\n

\n

Etonitazene<\/p>\n<\/td>\n

\n

1 \u2013 diethylaminoethyl \u2013 2 para<\/i> \u2013 ethoxybenzyl \u2013 5 \u2013 nitrobenzimidazole<\/p>\n<\/td>\n

\n

911-65-9<\/p>\n<\/td>\n<\/tr>\n

\n

35<\/p>\n<\/td>\n

\n

Etoxeridine<\/p>\n<\/td>\n

\n

1 \u2013 [2 \u2013 (2 \u2013 hydroxyethoxy) \u2013 ethyl] \u2013 4 \u2013 phenylpiperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

469-82-9<\/p>\n<\/td>\n<\/tr>\n

\n

36<\/p>\n<\/td>\n

\n

Fentanyl<\/p>\n<\/td>\n

\n

1 \u2013 phenethyl \u2013 4 \u2013 N<\/i> \u2013 propionylanilinopiperidine<\/p>\n<\/td>\n

\n

437-38-7<\/p>\n<\/td>\n<\/tr>\n

\n

37<\/p>\n<\/td>\n

\n

Furethidine<\/p>\n<\/td>\n

\n

1 \u2013 (2 \u2013 tetrahydrofurfuryloxyethyl) \u2013 4 \u2013 phenylpiperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

2385-81-1<\/p>\n<\/td>\n<\/tr>\n

\n

38<\/p>\n<\/td>\n

\n

Hydrocodone<\/p>\n<\/td>\n

\n

Dihydrocodeinone<\/p>\n<\/td>\n

\n

125-29-1<\/p>\n<\/td>\n<\/tr>\n

\n

39<\/p>\n<\/td>\n

\n

Hydromorphinol<\/p>\n<\/td>\n

\n

14 \u2013 hydroxydihydromorphine<\/p>\n<\/td>\n

\n

2183-56-4<\/p>\n<\/td>\n<\/tr>\n

\n

40<\/p>\n<\/td>\n

\n

Hydromorphone<\/p>\n<\/td>\n

\n

Dihydromorphinone<\/p>\n<\/td>\n

\n

466-99-9<\/p>\n<\/td>\n<\/tr>\n

\n

41<\/p>\n<\/td>\n

\n

Hydroxypethidine<\/p>\n<\/td>\n

\n

4 \u2013 meta <\/i>\u2013 hydroxyphenyl \u2013 1 \u2013 methylpiperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

468-56-4<\/p>\n<\/td>\n<\/tr>\n

\n

42<\/p>\n<\/td>\n

\n

Isomethadone<\/p>\n<\/td>\n

\n

6 \u2013 dimethylamino \u2013 5 \u2013 methyl \u2013 4,4 \u2013 diphenyl \u2013 3 \u2013 hexanone<\/p>\n<\/td>\n

\n

466-40-0<\/p>\n<\/td>\n<\/tr>\n

\n

43<\/p>\n<\/td>\n

\n

Levomethorphan<\/p>\n<\/td>\n

\n

(-) \u2013 3 \u2013 methoxy \u2013 N<\/i> \u2013 methylmorphinan<\/p>\n<\/td>\n

\n

125-68-8<\/p>\n<\/td>\n<\/tr>\n

\n

44<\/p>\n<\/td>\n

\n

Levomoramide<\/p>\n<\/td>\n

\n

(-) \u2013 4 \u2013 [2 \u2013 methyl \u2013 4 \u2013 oxo \u2013 3,3 \u2013 diphenyl \u2013 4 -(1 \u2013 pyrrolidinyl) butyl] morpholine<\/p>\n<\/td>\n

\n

5666-11-5<\/p>\n<\/td>\n<\/tr>\n

\n

45<\/p>\n<\/td>\n

\n

Levophenacylmorphan<\/p>\n<\/td>\n

\n

(-) \u2013 3 \u2013 hydroxy \u2013 N<\/i> \u2013 phenacylmorphinan<\/p>\n<\/td>\n

\n

10061-32-2<\/p>\n<\/td>\n<\/tr>\n

\n

46<\/p>\n<\/td>\n

\n

Levorphanol<\/p>\n<\/td>\n

\n

(-) \u2013 3 \u2013 hydroxy \u2013 N<\/i> \u2013 methylmorphinan<\/p>\n<\/td>\n

\n

77-07-6<\/p>\n<\/td>\n<\/tr>\n

\n

47<\/p>\n<\/td>\n

\n

Metazocine<\/p>\n<\/td>\n

\n

2\u2019 \u2013 hydroxy \u2013 2,5,9 \u2013 trimethyl \u2013 6,7 \u2013 benzomorphan<\/p>\n<\/td>\n

\n

3734-52-9<\/p>\n<\/td>\n<\/tr>\n

\n

48<\/p>\n<\/td>\n

\n

Methadone<\/p>\n<\/td>\n

\n

6 \u2013 dimethylamino \u2013 4,4 \u2013 diphenyl \u2013 3 \u2013 heptanone<\/p>\n<\/td>\n

\n

76-99-3<\/p>\n<\/td>\n<\/tr>\n

\n

49<\/p>\n<\/td>\n

\n

Methadone intermediate<\/p>\n<\/td>\n

\n

4 \u2013 cyano \u2013 2 dimethylamino \u2013 4,4 \u2013 diphenylbutane<\/p>\n<\/td>\n

\n

125-79-1<\/p>\n<\/td>\n<\/tr>\n

\n

50<\/p>\n<\/td>\n

\n

Methyldesorphine<\/p>\n<\/td>\n

\n

6 \u2013 methyl \u2013 delta<\/i> \u2013 6 \u2013 deoxymor phine<\/p>\n<\/td>\n

\n

16008-36-9<\/p>\n<\/td>\n<\/tr>\n

\n

51<\/p>\n<\/td>\n

\n

Methyldihydromorphine<\/p>\n<\/td>\n

\n

6 \u2013 methyldihydromorphine<\/p>\n<\/td>\n

\n

509-56-8<\/p>\n<\/td>\n<\/tr>\n

\n

52<\/p>\n<\/td>\n

\n

Metopon<\/p>\n<\/td>\n

\n

5 \u2013 methyldihydromorphinone<\/p>\n<\/td>\n

\n

143-52-2<\/p>\n<\/td>\n<\/tr>\n

\n

53<\/p>\n<\/td>\n

\n

Moramide<\/p>\n<\/td>\n

\n

2 \u2013 methyl \u2013 3 \u2013 morpholino \u2013 1,1 -diphenylpropane carboxylic acid<\/p>\n<\/td>\n

\n

545-59-5<\/p>\n<\/td>\n<\/tr>\n

\n

54<\/p>\n<\/td>\n

\n

Morpheridine<\/p>\n<\/td>\n

\n

1 \u2013 (2 \u2013 morpholinoethyl) \u2013 4 \u2013 phenylpiperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

469-81-8<\/p>\n<\/td>\n<\/tr>\n

\n

55<\/p>\n<\/td>\n

\n

Morphine<\/p>\n<\/td>\n

\n

7,8 \u2013 dehydro \u2013 4,5 \u2013 epoxy \u2013 3,6 \u2013 dihydroxy \u2013 N<\/i> \u2013 methylmorphinan<\/p>\n<\/td>\n

\n

57-27-2<\/p>\n<\/td>\n<\/tr>\n

\n

56<\/p>\n<\/td>\n

\n

Morphine \u2013 N \u2013 oxide<\/p>\n<\/td>\n

\n

3,6 \u2013 dihydroxy \u2013 N<\/i> \u2013 methyl \u2013 4,5 \u2013 epoxy \u2013 morphinen \u2013 7 \u2013 N<\/i> \u2013 oxide<\/p>\n<\/td>\n

\n

639-46-3<\/p>\n<\/td>\n<\/tr>\n

\n

57<\/p>\n<\/td>\n

\n

Myrophine<\/p>\n<\/td>\n

\n

Myristylbenzylmorphine<\/p>\n<\/td>\n

\n

467-18-5<\/p>\n<\/td>\n<\/tr>\n

\n

58<\/p>\n<\/td>\n

\n

Nicomorphine<\/p>\n<\/td>\n

\n

3,6 \u2013 dinicotinylmorphine<\/p>\n<\/td>\n

\n

639-48-5<\/p>\n<\/td>\n<\/tr>\n

\n

59<\/p>\n<\/td>\n

\n

Noracymethadol<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 \u03b1<\/i> \u2013 3 \u2013 acetoxy \u2013 6 \u2013 methylamino \u2013 4,4 \u2013 diphenyl \u2013 heptane<\/p>\n<\/td>\n

\n

1477-39-0<\/p>\n<\/td>\n<\/tr>\n

\n

60<\/p>\n<\/td>\n

\n

Norlevorphanol<\/p>\n<\/td>\n

\n

(-) \u2013 3 \u2013 hydroxymorphinan<\/p>\n<\/td>\n

\n

1531-12-0<\/p>\n<\/td>\n<\/tr>\n

\n

61<\/p>\n<\/td>\n

\n

Normethadone<\/p>\n<\/td>\n

\n

6 \u2013 dimethylamino \u2013 4,4 diphenyl \u2013 3 \u2013 hexanone<\/p>\n<\/td>\n

\n

467-85-6<\/p>\n<\/td>\n<\/tr>\n

\n

62<\/p>\n<\/td>\n

\n

Normorphine<\/p>\n<\/td>\n

\n

N <\/i>\u2013 demethylmorphine<\/p>\n<\/td>\n

\n

466-97-7<\/p>\n<\/td>\n<\/tr>\n

\n

63<\/p>\n<\/td>\n

\n

Norpipanone<\/p>\n<\/td>\n

\n

4,4 \u2013 diphenyl \u2013 6 \u2013 piperidino \u2013 3 \u2013 hexanone<\/p>\n<\/td>\n

\n

561-48-8<\/p>\n<\/td>\n<\/tr>\n

\n

64<\/p>\n<\/td>\n

\n

Oxycodone<\/p>\n<\/td>\n

\n

14 \u2013 hydroxydihydrocodeinone<\/p>\n<\/td>\n

\n

76-42-5<\/p>\n<\/td>\n<\/tr>\n

\n

65<\/p>\n<\/td>\n

\n

Oxymorphone<\/p>\n<\/td>\n

\n

14 \u2013 hydroxydihydromorphinone<\/p>\n<\/td>\n

\n

76-41-5<\/p>\n<\/td>\n<\/tr>\n

\n

66<\/p>\n<\/td>\n

\n

Pethidine<\/p>\n<\/td>\n

\n

1 \u2013 methyl \u2013 4 \u2013 phenylpiperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

57-42-1<\/p>\n<\/td>\n<\/tr>\n

\n

67<\/p>\n<\/td>\n

\n

Pethidine intermediate A<\/p>\n<\/td>\n

\n

4 \u2013 cyano \u2013 1 \u2013 methyl \u2013 4 \u2013 phenylpiperidine<\/p>\n<\/td>\n

\n

3627-62-1<\/p>\n<\/td>\n<\/tr>\n

\n

68<\/p>\n<\/td>\n

\n

Pethidine intermediate B<\/p>\n<\/td>\n

\n

4 \u2013 Phenylpiperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

77-17-8<\/p>\n<\/td>\n<\/tr>\n

\n

69<\/p>\n<\/td>\n

\n

Pethidine intermediate C<\/p>\n<\/td>\n

\n

1 \u2013 methyl \u2013 4 \u2013 phenylpiperidine \u2013 4 \u2013 carboxylic acid<\/p>\n<\/td>\n

\n

3627-48-3<\/p>\n<\/td>\n<\/tr>\n

\n

70<\/p>\n<\/td>\n

\n

Phenadoxone<\/p>\n<\/td>\n

\n

6 \u2013 morpholino \u2013 4,4 \u2013 diphenyl \u2013 3 \u2013 heptanone<\/p>\n<\/td>\n

\n

467-84-5<\/p>\n<\/td>\n<\/tr>\n

\n

71<\/p>\n<\/td>\n

\n

Phenampromide<\/p>\n<\/td>\n

\n

N<\/i> \u2013 (1 \u2013 methyl \u2013 2 \u2013 piperidinoethyl) propionanilide<\/p>\n<\/td>\n

\n

129-83-9<\/p>\n<\/td>\n<\/tr>\n

\n

72<\/p>\n<\/td>\n

\n

Phenazocine<\/p>\n<\/td>\n

\n

2\u2019 \u2013 hydroxy \u2013 5,9 \u2013 dimethyl \u2013 2 \u2013 phenethyl \u2013 6, 7 \u2013 benzomorphan<\/p>\n<\/td>\n

\n

127-35-5<\/p>\n<\/td>\n<\/tr>\n

\n

73<\/p>\n<\/td>\n

\n

Phenomorphan<\/p>\n<\/td>\n

\n

3 \u2013 hydroxy \u2013 N<\/i> \u2013 phenethylmorphinan<\/p>\n<\/td>\n

\n

468-07-5<\/p>\n<\/td>\n<\/tr>\n

\n

74<\/p>\n<\/td>\n

\n

Phenoperidine<\/p>\n<\/td>\n

\n

1 \u2013 (3 \u2013 hydroxy \u2013 3 \u2013 phenylpropyl) \u2013 4 \u2013 phenylpiperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

562-26-5<\/p>\n<\/td>\n<\/tr>\n

\n

75<\/p>\n<\/td>\n

\n

Piminodine<\/p>\n<\/td>\n

\n

4 \u2013 phenyl \u2013 1 \u2013 (3 \u2013 phenylaminopropyl) \u2013 piperidine \u2013 4 \u2013 carboxylic acid ethyl ester<\/p>\n<\/td>\n

\n

13495-09-5<\/p>\n<\/td>\n<\/tr>\n

\n

76<\/p>\n<\/td>\n

\n

Piritramide<\/p>\n<\/td>\n

\n

1- (3 \u2013 cyano \u2013 3,3 \u2013 diphenylpropyl) \u2013 4 \u2013 (1 \u2013 piperidino) \u2013 piperidine \u2013 4 \u2013 carboxylic acid amide<\/p>\n<\/td>\n

\n

302-41-0<\/p>\n<\/td>\n<\/tr>\n

\n

77<\/p>\n<\/td>\n

\n

Proheptazine<\/p>\n<\/td>\n

\n

1,3 \u2013 dimethyl \u2013 4 \u2013 phenyl \u2013 4 \u2013 propionoxyazacycloheptane<\/p>\n<\/td>\n

\n

77-14-5<\/p>\n<\/td>\n<\/tr>\n

\n

78<\/p>\n<\/td>\n

\n

Properidine<\/p>\n<\/td>\n

\n

1 \u2013 methyl \u2013 4 \u2013 phenylpiperidine \u2013 4 \u2013 carboxylic acid isopropyl ester<\/p>\n<\/td>\n

\n

561-76-2<\/p>\n<\/td>\n<\/tr>\n

\n

79<\/p>\n<\/td>\n

\n

Racemethorphan<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 3 \u2013 methoxy \u2013 N<\/i> \u2013 methylmorphinan<\/p>\n<\/td>\n

\n

510-53-2<\/p>\n<\/td>\n<\/tr>\n

\n

80<\/p>\n<\/td>\n

\n

Racemoramide<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 4 \u2013 [2 \u2013 methyl \u2013 4 \u2013 oxo \u2013 3,3 \u2013 diphenyl \u2013 4 \u2013 (1 \u2013 pyrrolidinyl)butyl] morpholine<\/p>\n<\/td>\n

\n

545-59-5<\/p>\n<\/td>\n<\/tr>\n

\n

81<\/p>\n<\/td>\n

\n

Racemorphan<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 3 \u2013 hydroxy \u2013 N<\/i> \u2013 methylmorphinan<\/p>\n<\/td>\n

\n

297-90-5<\/p>\n<\/td>\n<\/tr>\n

\n

82<\/p>\n<\/td>\n

\n

Remifentanil<\/p>\n<\/td>\n

\n

1 \u2013 (2 \u2013 methoxycarbonylethyl) \u2013 4 \u2013 (phenylpropionylamino)-piperidine \u2013 4carboxylic acid methyl ester<\/p>\n<\/td>\n

\n

132875-61-7<\/p>\n<\/td>\n<\/tr>\n

\n

83<\/p>\n<\/td>\n

\n

Sulfentanil<\/p>\n<\/td>\n

\n

N<\/i> \u2013 [4 \u2013 (methoxymethyl) \u2013 1- [2 \u2013 (2 \u2013 thienyl) \u2013 ethyl] \u2013 4 \u2013 piperidyl] propionanilide<\/p>\n<\/td>\n

\n

56030-54-7<\/p>\n<\/td>\n<\/tr>\n

\n

84<\/p>\n<\/td>\n

\n

Thebacon<\/p>\n<\/td>\n

\n

Acethyldihydrocodeinone<\/p>\n<\/td>\n

\n

466-90-0<\/p>\n<\/td>\n<\/tr>\n

\n

85<\/p>\n<\/td>\n

\n

Thebaine<\/p>\n<\/td>\n

\n

3,6 \u2013 dimethoxy \u2013 N<\/i> \u2013 methyl \u2013 4,5 \u2013 epoxymorphinadien \u2013 6,8<\/p>\n<\/td>\n

\n

115-37-7<\/p>\n<\/td>\n<\/tr>\n

\n

86<\/p>\n<\/td>\n

\n

Tilidine<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 ethyl \u2013 trans \u2013 2 \u2013 (dimethylamino) \u2013 1 \u2013 phenyl \u2013 3 \u2013 cyclohexene \u2013 1 \u2013 carboxylate<\/p>\n<\/td>\n

\n

20380-58-9<\/p>\n<\/td>\n<\/tr>\n

\n

87<\/p>\n<\/td>\n

\n

Trimeperidine<\/p>\n<\/td>\n

\n

1,2,5 \u2013 trimethyl \u2013 4 \u2013 phenyl \u2013 4 \u2013 propionoxypiperidine<\/p>\n<\/td>\n

\n

64-39-1<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

IIB. C\u00e1c ch\u1ea5t v\u00e0 mu\u1ed1i, \u0111\u1ed3ng ph\u00e2n c\u00f3 th\u1ec3 t\u1ed3n t\u1ea1i c\u1ee7a c\u00e1c ch\u1ea5t n\u00e0y<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin CAS<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

88<\/p>\n<\/td>\n

\n

25B-NBOMe<\/p>\n<\/td>\n

\n

2- (4 \u2013 bromo \u2013 2,5 -dimethoxyphenyl) \u2013 N<\/i> [(2-methoxyphenyl) methyl] ethanamine<\/p>\n<\/td>\n

\n

1026511-90-9<\/p>\n<\/td>\n<\/tr>\n

\n

89<\/p>\n<\/td>\n

\n

25C-NBOMe<\/p>\n<\/td>\n

\n

2- (4-chloro-2,5-dimethoxyphenyl) \u2013 N<\/i> \u2013 [(2-methoxyphenyl) methyl] ethanamine<\/p>\n<\/td>\n

\n

1227608-02-7<\/p>\n<\/td>\n<\/tr>\n

\n

90<\/p>\n<\/td>\n

\n

25I-NBOMe<\/p>\n<\/td>\n

\n

2- (4-iodo-2,5-dimethoxyphenyl) \u2013N<\/i>\u00a0\u2013 [(2-methoxyphenyl) methyl] ethanamine<\/p>\n<\/td>\n

\n

919797-19-6<\/p>\n<\/td>\n<\/tr>\n

\n

91<\/p>\n<\/td>\n

Acetyldihydrocodeine<\/td>\n(5\u03b1<\/i>, 6\u03b1<\/i>) \u2013 4,5 \u2013 epoxy \u2013 3 \u2013 methoxy \u2013 17 \u2013 methyl \u2013 morphinan \u2013 6 \u2013 ol acetat<\/td>\n\n

3861-72-1<\/p>\n<\/td>\n<\/tr>\n

\n

92<\/p>\n<\/td>\n

\n

Amphetamine<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 \u03b1<\/i> \u2013 methylphenethylamine<\/p>\n<\/td>\n

\n

300-62-9<\/p>\n<\/td>\n<\/tr>\n

\n

93<\/p>\n<\/td>\n

\n

Codeine (3 \u2013 methylmorphine)<\/p>\n<\/td>\n

\n

6 \u2013 hydroxy \u2013 3 \u2013 methoxy \u2013 N<\/i> \u2013 methyl \u2013 4,5 \u2013 epoxy \u2013 morphinen \u2013 7<\/p>\n<\/td>\n

\n

76-57-3<\/p>\n<\/td>\n<\/tr>\n

\n

94<\/p>\n<\/td>\n

Dextropropoxyphene<\/td>\n\n

\u03b1<\/i> \u2013 (+) \u2013 4 \u2013 dimethylamino \u2013 1,2 \u2013 diphenyl \u2013 3 \u2013 methyl \u2013 2 \u2013 butanol propionate<\/p>\n<\/td>\n

\n

469-62-5<\/p>\n<\/td>\n<\/tr>\n

\n

95<\/p>\n<\/td>\n

\n

Dihydrocodeine<\/p>\n<\/td>\n

\n

6 \u2013 hydroxy \u2013 3 \u2013 methoxy \u2013 N<\/i> \u2013 methyl \u2013 4,5 \u2013 epoxy \u2013 morphinan<\/p>\n<\/td>\n

\n

125-28-0<\/p>\n<\/td>\n<\/tr>\n

\n

96<\/p>\n<\/td>\n

\n

Ethylmorphine<\/p>\n<\/td>\n

\n

3 \u2013 Ethylmorphine<\/p>\n<\/td>\n

\n

76-58-4<\/p>\n<\/td>\n<\/tr>\n

\n

97<\/p>\n<\/td>\n

\n

Methylphenidate<\/p>\n<\/td>\n

\n

Methyl \u2013 \u03b1<\/i> \u2013 phenyl \u2013 2 \u2013 piperidineacetate<\/p>\n<\/td>\n

\n

113-45-1<\/p>\n<\/td>\n<\/tr>\n

\n

98<\/p>\n<\/td>\n

\n

Nicocodine<\/p>\n<\/td>\n

\n

6 \u2013 nicotinylcodeine<\/p>\n<\/td>\n

\n

3688-66-2<\/p>\n<\/td>\n<\/tr>\n

\n

99<\/p>\n<\/td>\n

\n

Nicodicodine<\/p>\n<\/td>\n

\n

6 \u2013 nicotinyldihydrocodeine<\/p>\n<\/td>\n

\n

808-24-2<\/p>\n<\/td>\n<\/tr>\n

\n

100<\/p>\n<\/td>\n

\n

Norcodeine<\/p>\n<\/td>\n

\n

N<\/i> \u2013 demethylcodeine<\/p>\n<\/td>\n

\n

467-15-2<\/p>\n<\/td>\n<\/tr>\n

\n

101<\/p>\n<\/td>\n

\n

PMMA<\/p>\n<\/td>\n

\n

Para<\/i>-methoxy methamphetamine<\/p>\n<\/td>\n

\n

3398-68-3<\/p>\n<\/td>\n<\/tr>\n

\n

102<\/p>\n<\/td>\n

\n

Propiram<\/p>\n<\/td>\n

\n

N<\/i> \u2013 (1 \u2013 methyl \u2013 2 \u2013 piperidinoethyl) \u2013 N<\/i> \u2013 2 \u2013 pyridylpropionamide<\/p>\n<\/td>\n

\n

15686-91-6<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

IIC. C\u00e1c ch\u1ea5t v\u00e0 mu\u1ed1i c\u00f3 th\u1ec3 t\u1ed3n t\u1ea1i c\u1ee7a c\u00e1c ch\u1ea5t n\u00e0y<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin CAS<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

103<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-3-(2-ethylbenzoyl)indole)<\/p>\n<\/td>\n

\n

(2-ethylphenyl) (1-(5-fluoropentyl)- 1H<\/i>-indol-3-yl) methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

104<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-3-(2-methylbenzoyl)indole)<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-1H<\/i>-indol-3-yl)(o-tolyl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

105<\/p>\n<\/td>\n

\n

(1-Pentyl-1H<\/i>-indazol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone<\/p>\n<\/td>\n

\n

(1-Pentyl-1H<\/i>-indazol-3-yl) (2,2,3,3-tetramethylcyclopropyl) methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

106<\/p>\n<\/td>\n

\n

(1-pentyl-1H<\/i>-indazol-3-yl)piperazin-1-yl)methanone<\/p>\n<\/td>\n

\n

(1-pentyl-1H<\/i>-indazol-3-yl) piperazin-1-yl) methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

107<\/p>\n<\/td>\n

\n

(1-Pentyl-1H<\/i>-indol-3-yl)(pyridin-3-yl)methanone<\/p>\n<\/td>\n

\n

(1-Pentyl-1H<\/i>-indol-3-yl) (pyridin-3-yl) methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

108<\/p>\n<\/td>\n

\n

(1-pentyl-1H<\/i>-indol-3-yl)piperazin-1-yl)methanone<\/p>\n<\/td>\n

\n

(1-pentyl-1H<\/i>-indol-3-yl) piperazin-1-yl) methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

109<\/p>\n<\/td>\n

\n

1-(Cyclohexylmethyl)-2-[(4-ethoxyphenyl)methyl]-N,N<\/i>-diethyl-1H<\/i>-benzimidazol-5-carboxamide<\/p>\n<\/td>\n

\n

1-(cyclohexylmethyl)-2 -(4-ethoxybenzyl)-N<\/i>,N<\/i>-diethyl-1H<\/i>-benzo[d<\/i>]imidazole-5-carboxamide<\/p>\n<\/td>\n

\n

1046140-32-2<\/p>\n<\/td>\n<\/tr>\n

\n

110<\/p>\n<\/td>\n

\n

1-(Phenylmethyl)-1H<\/i>-indole-3-carboxylic acid 8-quinolinyl ester<\/p>\n<\/td>\n

\n

quinolin-8-yl 1-benzyl-1H<\/i>-indole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

111<\/p>\n<\/td>\n

\n

1-Benzyl-N<\/i>-(quinolin-8-yl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1-benzyl-N<\/i>-(quinolin-8-yl)- 1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

112<\/p>\n<\/td>\n

\n

1-Benzyl-N<\/i>-(quinolin-8-yl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

1-benzyl-N<\/i>-(quinolin-8-yl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

113<\/p>\n<\/td>\n

\n

1-Pentyl-N-(quinolin-8-yl)-1H-indole-3-carboxamide<\/p>\n<\/td>\n

\n

1-pentyl-N<\/i>-(quinolin-8-yl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

114<\/p>\n<\/td>\n

\n

2C-B<\/p>\n<\/td>\n

\n

4-Bromo-2,5-dimethoxyphenethylamine<\/p>\n<\/td>\n

\n

66142-81-2<\/p>\n<\/td>\n<\/tr>\n

\n

115<\/p>\n<\/td>\n

\n

2C-E<\/p>\n<\/td>\n

\n

4 \u2013 ethyl \u2013 2,5 \u2013 Dimethoxyphenethylamine<\/p>\n<\/td>\n

\n

71539-34-9<\/p>\n<\/td>\n<\/tr>\n

\n

116<\/p>\n<\/td>\n

\n

2C-H<\/p>\n<\/td>\n

\n

2,5-dimethoxy-phenethylamine<\/p>\n<\/td>\n

\n

3600-86-0<\/p>\n<\/td>\n<\/tr>\n

\n

117<\/p>\n<\/td>\n

\n

3-(4-Hydroxymethylbenzoyl)-1-pentylindole<\/p>\n<\/td>\n

\n

(4-(hydroxymethyl)phenyl)(1-pentyl-1H-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

118<\/p>\n<\/td>\n

\n

3-(5-Benzyl-1,3,4-oxadiazol-2-yl)-1-(2-morpholin-4-ylethyl)-1H-indole<\/p>\n<\/td>\n

\n

4-(2-(3-(5-benzyl-1,3,4-oxadiazol-2-yl)-1H<\/i>-indol-1-yl)ethyl)morpholine<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

119<\/p>\n<\/td>\n

\n

3-(5-Benzyl-1,3,4-oxadiazol-2-yl)-1-(2-pyrrolidin-1-ylethyl)-1H-indole<\/p>\n<\/td>\n

\n

2-benzyl-5-(1-(2-(pyrrolidin-1-yl)ethyl)-1H<\/i>-indol-3-yl)-1,3,4-oxadiazole<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

120<\/p>\n<\/td>\n

\n

3-Meo-PCP<\/p>\n<\/td>\n

\n

1-[1-(3-methoxyphenyl)cyclohexy]-piperidine<\/p>\n<\/td>\n

\n

72242-03-6<\/p>\n<\/td>\n<\/tr>\n

\n

121<\/p>\n<\/td>\n

\n

4,4\u2019-DMAR<\/p>\n<\/td>\n

\n

Para<\/i>-methyl-4-methylaminorex<\/p>\n<\/td>\n

\n

364064-08-4<\/p>\n<\/td>\n<\/tr>\n

\n

122<\/p>\n<\/td>\n

\n

4-CEC<\/p>\n<\/td>\n

\n

1-(4-Chlorophenyl)-2-(ethy lamino)-1-propanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

123<\/p>\n<\/td>\n

\n

4-HO-DiPT<\/p>\n<\/td>\n

\n

3-[2-(diisopropylamino) ethyl]-1H<\/i>-indol-4-ol<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

124<\/p>\n<\/td>\n

\n

4-Hydroxy-3,3,4-trimethyl-1-(1-pentyl-1H-indol-3-yl)pentan-1-one<\/p>\n<\/td>\n

\n

4-hydroxy-3,3,4-trimethyl-1-(1-pentyl-1H<\/i>-indol-3-yl)pentan-1-one<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

125<\/p>\n<\/td>\n

\n

4-methylcanthinone<\/p>\n<\/td>\n

\n

2-amino-1- (4-metylphenyl) propan-1-one<\/p>\n<\/td>\n

\n

31952-47-3<\/p>\n<\/td>\n<\/tr>\n

\n

126<\/p>\n<\/td>\n

\n

5-APB<\/p>\n<\/td>\n

\n

1-Benzofuran-5-ylpropan-2-amine<\/p>\n<\/td>\n

\n

286834-81-9<\/p>\n<\/td>\n<\/tr>\n

\n

127<\/p>\n<\/td>\n

\n

5C-AKB48<\/p>\n<\/td>\n

\n

N<\/i>-(adamantan-1-yl)-1-(5-chloropentyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

128<\/p>\n<\/td>\n

\n

5-Chloro-NNE1<\/p>\n

(5-Cl-MN-24)<\/p>\n<\/td>\n

\n

1-(5-chloropentyl)-N<\/i>-(naphthalen-1-yl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

129<\/p>\n<\/td>\n

\n

5-Cl-AB-PINACA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-chloropentyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

130<\/p>\n<\/td>\n

\n

5F-AB-001<\/p>\n<\/td>\n

\n

adamantan-1-yl(1-(5-fluoropentyl)-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

131<\/p>\n<\/td>\n

\n

5F-AB-FUPPYCA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-5-(4-fluorophenyl)-1H<\/i>-pyrazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

132<\/p>\n<\/td>\n

\n

5F-AB-PINACA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1800101-60-3<\/p>\n<\/td>\n<\/tr>\n

\n

133<\/p>\n<\/td>\n

\n

5F-ADBICA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

1863065-82-0<\/p>\n<\/td>\n<\/tr>\n

\n

134<\/p>\n<\/td>\n

\n

5F-ADB-PINACA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1863065-90-0<\/p>\n<\/td>\n<\/tr>\n

\n

135<\/p>\n<\/td>\n

\n

5F-AEB<\/p>\n<\/td>\n

\n

ethyl (1-(5-fluoropentyl)-1H<\/i>-indazole-3-carbonyl)-L-valinate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

136<\/p>\n<\/td>\n

\n

5F-AKB48<\/p>\n

(5F-APINACA)<\/p>\n<\/td>\n

\n

N<\/i>-(adamantan-1-yl)-1-(5-fluoropentyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1400742-13-3<\/p>\n<\/td>\n<\/tr>\n

\n

137<\/p>\n<\/td>\n

\n

5F-AMB<\/p>\n<\/td>\n

\n

methyl (1-(5-fluoropentyl)-1H<\/i>-indazole-3-carbonyl)valinate<\/p>\n<\/td>\n

\n

1801552-03-3<\/p>\n<\/td>\n<\/tr>\n

\n

138<\/p>\n<\/td>\n

\n

5F-AMBICA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

139<\/p>\n<\/td>\n

\n

5F-APICA<\/p>\n<\/td>\n

\n

N<\/i>-(adamantan-1-yl)-1-(5-fluoropentyl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

1354631-26-7<\/p>\n<\/td>\n<\/tr>\n

\n

140<\/p>\n<\/td>\n

\n

5F-APP-PINACA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

141<\/p>\n<\/td>\n

\n

5F-EMB-PINACA<\/p>\n<\/td>\n

\n

Ethyl 2-[[1-(5-fluoropentyl)indazole-3-carbonyl]amino]-3-methyl-butanoate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

142<\/p>\n<\/td>\n

\n

5F-INPB-22<\/p>\n<\/td>\n

\n

quinolin-8-yl 1-(5-fluoropentyl)-1H<\/i>-indazole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

143<\/p>\n<\/td>\n

\n

5-fluoropentyl-3-pyridinoylindole<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-1H<\/i>-indol-3-yl)(pyridin-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

144<\/p>\n<\/td>\n

\n

5F-MDMB-PINACA<\/p>\n<\/td>\n

\n

methyl 2-(1-(5-fluoropentyl)-1H<\/i>-indazole-3-carboxamido)-3,3-dimethylbutanoate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

145<\/p>\n<\/td>\n

\n

5F-MMB-PICA<\/p>\n<\/td>\n

\n

methyl (1-(5-fluoropentyl)-1H<\/i>-indole-3-carbonyl)valinate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

146<\/p>\n<\/td>\n

\n

5F-MN-18<\/p>\n<\/td>\n

\n

1-(5-fluoropentyl)-N<\/i>-(naphthalen-1-yl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

147<\/p>\n<\/td>\n

\n

5F-MN-24\u00a0<\/p>\n<\/td>\n

\n

1-(5-fluoropentyl)-N<\/i>-(naphthalen-1-yl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

1445580-60-8<\/p>\n<\/td>\n<\/tr>\n

\n

148<\/p>\n<\/td>\n

\n

5F-PB-22\u00a0<\/p>\n<\/td>\n

\n

quinolin-8-yl 1-(5-fluoropentyl)-1H<\/i>-indole-3-carboxylate<\/p>\n<\/td>\n

\n

1411742-41-7<\/p>\n<\/td>\n<\/tr>\n

\n

149<\/p>\n<\/td>\n

\n

5F-PCN<\/p>\n<\/td>\n

\n

1-(5-fluoropentyl)-N<\/i>-(naphthalen-1-yl)-1H<\/i>-pyrrolo[3,2-c]pyridine-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

150<\/p>\n<\/td>\n

\n

5F-PY-PICA<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-1H<\/i>-indol-3-yl)(pyrrolidin-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

151<\/p>\n<\/td>\n

\n

5F-PY-PINACA<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-1H<\/i>-indazol-3-yl)(pyrrolidin-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

152<\/p>\n<\/td>\n

\n

5F-SDB-005<\/p>\n<\/td>\n

\n

naphthalen-1-yl 1-(5-fluoropentyl)-1H<\/i>-indazole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

153<\/p>\n<\/td>\n

\n

5F-SDB-006<\/p>\n<\/td>\n

\n

N<\/i>-benzyl-1-(5-fluoropentyl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

776086-02-2<\/p>\n<\/td>\n<\/tr>\n

\n

154<\/p>\n<\/td>\n

\n

5F-THJ (5F-THJ-018)<\/p>\n<\/td>\n

\n

1-(5-fluoropentyl)-N<\/i>-(quinolin-8-yl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

155<\/p>\n<\/td>\n

\n

5F-UR-144 indazole<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-1H<\/i>-indazol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

156<\/p>\n<\/td>\n

\n

5-Meo-DiPT<\/p>\n<\/td>\n

\n

3- [2- (diisopropylamino) ethyl] -5-methoxyindole<\/p>\n<\/td>\n

\n

4021-34-5<\/p>\n<\/td>\n<\/tr>\n

\n

157<\/p>\n<\/td>\n

\n

5-MeO-MiPT<\/p>\n<\/td>\n

\n

N<\/i> \u2013 [2- (5-methoxy-1H<\/i> -indol-3-yl) ethyl] \u2013 N<\/i> -methylpropan-2-amin<\/p>\n<\/td>\n

\n

96096-55-8<\/p>\n<\/td>\n<\/tr>\n

\n

158<\/p>\n<\/td>\n

\n

A-796,260<\/p>\n<\/td>\n

\n

(1-(2-morpholinoethyl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone\u00a0<\/p>\n<\/td>\n

\n

895155-26-7<\/p>\n<\/td>\n<\/tr>\n

\n

159<\/p>\n<\/td>\n

\n

A-796,260 isomer<\/p>\n<\/td>\n

\n

E)-3,4,4-trimethyl-1-(1-(2-morpholinoethyl)-1H<\/i>-indol-3-yl)pent-2-en-1-one<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

160<\/p>\n<\/td>\n

\n

A-834,735<\/p>\n<\/td>\n

\n

(1-((tetrahydro-2H<\/i>-pyran-4-yl)methyl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone\u00a0<\/p>\n<\/td>\n

\n

895155-57-4<\/p>\n<\/td>\n<\/tr>\n

\n

161<\/p>\n<\/td>\n

\n

A-836,339<\/p>\n<\/td>\n

\n

(E)-N<\/i>-(3-(2-methoxyethyl)-4,5-dimethylthiazol-2(3H<\/i>)-ylidene)-2,2,3,3-tetramethylcyclopropane-1-carboxamide<\/p>\n<\/td>\n

\n

959746-77-1<\/p>\n<\/td>\n<\/tr>\n

\n

162<\/p>\n<\/td>\n

\n

AB-005\u00a0<\/p>\n<\/td>\n

\n

(1-((1-methylpiperidin-2-yl)methyl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone<\/p>\n<\/td>\n

\n

895155-25-6<\/p>\n<\/td>\n<\/tr>\n

\n

163<\/p>\n<\/td>\n

\n

AB-005 azepane<\/p>\n<\/td>\n

\n

(1-(1-methylazepan-3-yl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

164<\/p>\n<\/td>\n

\n

AB-CHMFUPPYCA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H<\/i>-pyrazole-5-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

165<\/p>\n<\/td>\n

\n

AB-CHMICA<\/p>\n<\/td>\n

\n

(S)-N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

166<\/p>\n<\/td>\n

\n

AB-CHMINACA\u00a0<\/p>\n<\/td>\n

\n

(S)-N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1185887-21-1<\/p>\n<\/td>\n<\/tr>\n

\n

167<\/p>\n<\/td>\n

\n

AB-CHMINACA 2\u2019-indazole<\/p>\n<\/td>\n

\n

(S)-N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-2-(cyclohexylmethyl)-2H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

168<\/p>\n<\/td>\n

\n

AB-FUBINACA\u00a0<\/p>\n<\/td>\n

\n

(S)-N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1185282-01-2<\/p>\n<\/td>\n<\/tr>\n

\n

169<\/p>\n<\/td>\n

\n

AB-FUBINACA 2-fluorobenzyl<\/p>\n<\/td>\n

\n

(S)-N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(2-fluorobenzyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1185282-16-9<\/p>\n<\/td>\n<\/tr>\n

\n

170<\/p>\n<\/td>\n

\n

AB-PICA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

171<\/p>\n<\/td>\n

\n

AB-PINACA\u00a0<\/p>\n<\/td>\n

\n

(S)-N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1445752-09-9<\/p>\n<\/td>\n<\/tr>\n

\n

172<\/p>\n<\/td>\n

\n

AB-PINACA N-(2-fluoropentyl)<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(2-fluoropentyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

173<\/p>\n<\/td>\n

\n

AB-PINACA N-(3-fluoropentyl)<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(3-fluoropentyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

174<\/p>\n<\/td>\n

\n

AB-PINACA N-(4-fluoropentyl)<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluoropentyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

175<\/p>\n<\/td>\n

\n

AB-PINACA N-(5-fluoropentyl)<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

176<\/p>\n<\/td>\n

\n

AB-PINACA-N- FluoroPentyl<\/p>\n<\/td>\n

\n

N<\/i>\u2013 (1-amino 3 methyl- 1- oxobutan- 2-yl) \u2013 1- fluoropentyl) \u2013 1H<\/i>\u2013 indazole- 3 cacboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

177<\/p>\n<\/td>\n

\n

Acetyl fentanyl<\/p>\n<\/td>\n

\n

N<\/i> \u2013 (1-Phenethylpiperidin-4-yl) \u2013 N<\/i> -phenylacetamide<\/p>\n<\/td>\n

\n

3258-84-2<\/p>\n<\/td>\n<\/tr>\n

\n

178<\/p>\n<\/td>\n

\n

Adamantyl-THPINACA<\/p>\n<\/td>\n

\n

N<\/i>-(adamantan-1-yl)-1-((tetrahydro-2H<\/i>-pyran-4-yl)methyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

179<\/p>\n<\/td>\n

\n

ADB-CHMICA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

180<\/p>\n<\/td>\n

\n

ADB-CHMINACA (MAB-CHMINACA)<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

181<\/p>\n<\/td>\n

\n

ADB-FUBICA<\/p>\n<\/td>\n

\n

(S)-N<\/i>-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

182<\/p>\n<\/td>\n

\n

ADB-FUBINACA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1445583-51-6<\/p>\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

183<\/p>\n<\/td>\n

\n

ADBICA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

1445583-48-1<\/p>\n<\/td>\n<\/tr>\n

\n

184<\/p>\n<\/td>\n

\n

ADB-PINACA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1633766-73-0<\/p>\n<\/td>\n<\/tr>\n

\n

185<\/p>\n<\/td>\n

\n

ADSB-FUB-187<\/p>\n<\/td>\n

\n

7-chloro-N<\/i>-(1-((2-(cyclopropanesulfonamido)ethyl)amino)-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

186<\/p>\n<\/td>\n

\n

AKB-57<\/p>\n<\/td>\n

\n

adamantan-1-yl 1-pentyl-1H<\/i>-indazole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

187<\/p>\n<\/td>\n

\n

\u0391lpha<\/i> -Pyrrolidinopentiophenone<\/p>\n<\/td>\n

\n

(RS<\/i>)-1-Phenyl-2-(1-pyrrolidinyl)-1-pentanone<\/p>\n<\/td>\n

\n

14530-33-7<\/p>\n<\/td>\n<\/tr>\n

\n

188<\/p>\n<\/td>\n

\n

AM-1220<\/p>\n<\/td>\n

\n

(1-((1-methylpiperidin-2-yl)methyl)-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

134959-64-1<\/p>\n<\/td>\n<\/tr>\n

\n

189<\/p>\n<\/td>\n

\n

AM-1220 azepane<\/p>\n<\/td>\n

\n

(1-((1-methylazepan-3-yl)methyl)-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

190<\/p>\n<\/td>\n

\n

AM-1241<\/p>\n<\/td>\n

\n

(2-iodo-5-nitrophenyl)(1-((1-methylpiperidin-2-yl)methyl)-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

444912-48-5<\/p>\n<\/td>\n<\/tr>\n

\n

191<\/p>\n<\/td>\n

\n

AM-1248<\/p>\n<\/td>\n

\n

adamantan-1-yl(1-((1-methylpiperidin-2-yl)methyl)-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

192<\/p>\n<\/td>\n

\n

AM-1248 azepane<\/p>\n<\/td>\n

\n

adamantan-1-yl(1-(1-methylazepan-3-yl)-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

193<\/p>\n<\/td>\n

\n

AM-2201<\/p>\n<\/td>\n

\n

1 \u2013 [(5-fluoropentyl) -1H<\/i>\u00a0-indole-3-yl] \u2013 (naphthalen-1-yl) methanone<\/p>\n<\/td>\n

\n

335161-24-5<\/p>\n<\/td>\n<\/tr>\n

\n

194<\/p>\n<\/td>\n

\n

AM-2201 4-methoxynaphtyl<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-1H<\/i>-indol-3-yl)(4-methoxynaphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

195<\/p>\n<\/td>\n

\n

AM-2201 N-(4-fluoropentyl)<\/p>\n<\/td>\n

\n

(1-(4-fluoropentyl)-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

196<\/p>\n<\/td>\n

\n

AM-2232\u00a0<\/p>\n<\/td>\n

\n

5-(3-(1-naphthoyl)-1H<\/i>-indol-1-yl)pentanenitrile<\/p>\n<\/td>\n

\n

335161-19-8<\/p>\n<\/td>\n<\/tr>\n

\n

197<\/p>\n<\/td>\n

\n

AM-2233\u00a0<\/p>\n<\/td>\n

\n

(2-iodophenyl)(1-((1-methylpiperidin-2-yl)methyl)-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

444912-75-8<\/p>\n<\/td>\n<\/tr>\n

\n

198<\/p>\n<\/td>\n

\n

AM-356<\/p>\n<\/td>\n

\n

(5Z,8Z,11Z,14Z)-N<\/i>-((R)-1-hydroxypropan-2-yl)icosa-5,8,11,14-tetraenamide<\/p>\n<\/td>\n

\n

157182-49-5<\/p>\n<\/td>\n<\/tr>\n

\n

199<\/p>\n<\/td>\n

\n

AM-6527 N-(5-fluoropentyl)<\/p>\n<\/td>\n

\n

1-(5-fluoropentyl)-N<\/i>-(naphthalen-2-yl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

200<\/p>\n<\/td>\n

\n

AM-679\u00a0<\/p>\n<\/td>\n

\n

(2-iodophenyl)(1-pentyl-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

335160-91-3<\/p>\n<\/td>\n<\/tr>\n

\n

201<\/p>\n<\/td>\n

\n

AM-694\u00a0<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-1H<\/i>-indol-3-yl)(2-iodophenyl)methanone<\/p>\n<\/td>\n

\n

335161-03-0<\/p>\n<\/td>\n<\/tr>\n

\n

202<\/p>\n<\/td>\n

\n

AM-694 (Chloro)<\/p>\n<\/td>\n

\n

(1-(5-chloropentyl)-1H<\/i>-indol-3-yl)(2-iodophenyl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

203<\/p>\n<\/td>\n

\n

AMB<\/p>\n<\/td>\n

\n

methyl (1-pentyl-1H<\/i>-indazole-3-carbonyl)-L-valinate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

204<\/p>\n<\/td>\n

\n

AMB-CHMICA<\/p>\n

(MMB-CHMICA)<\/p>\n<\/td>\n

\n

methyl (1-(cyclohexylmethyl)-1H<\/i>-indole-3-carbonyl)valinate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

205<\/p>\n<\/td>\n

\n

AMB-CHMINACA<\/p>\n<\/td>\n

\n

methyl (1-(cyclohexylmethyl)-1H<\/i>-indazole-3-carbonyl)-valinate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

206<\/p>\n<\/td>\n

\n

AMB-FUBINACA<\/p>\n<\/td>\n

\n

methyl (2 S) -2 \u2013 {[1 \u2013 [(4-flophenyl) methyl] indazole-3-cacbonyl] amin} -3-methylbutanoate<\/p>\n<\/td>\n

\n

1715016-76-4<\/p>\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

207<\/p>\n<\/td>\n

\n

APICA\u00a0<\/p>\n<\/td>\n

\n

N<\/i>-(adamantan-1-yl)-1-pentyl-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

1345973-50-3<\/p>\n<\/td>\n<\/tr>\n

\n

208<\/p>\n<\/td>\n

\n

APINACA\u00a0<\/p>\n

(AKB48)<\/p>\n<\/td>\n

\n

N<\/i>-(adamantan-1-yl)-1-pentyl-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1345973-53-6<\/p>\n<\/td>\n<\/tr>\n

\n

209<\/p>\n<\/td>\n

\n

APP-CHMINACA<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(cyclohexylmethyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1185887-14-2<\/p>\n<\/td>\n<\/tr>\n

\n

210<\/p>\n<\/td>\n

\n

Butyrfentanyl<\/p>\n<\/td>\n

\n

N<\/i>-(1-phenethylpiperidin-4-yl)-N<\/i>-phenylbutyramide<\/p>\n<\/td>\n

\n

1169-70-6<\/p>\n<\/td>\n<\/tr>\n

\n

211<\/p>\n<\/td>\n

\n

BZP<\/p>\n<\/td>\n

\n

1-Benzylpiperazine<\/p>\n<\/td>\n

\n

2759-28-6<\/p>\n<\/td>\n<\/tr>\n

\n

212<\/p>\n<\/td>\n

\n

Cannabipiperidiethanone<\/p>\n<\/td>\n

\n

2-(2-methoxyphenyl)-1-(1-((1-methylpiperidin-2-yl)methyl)-1H<\/i>-indol-3-yl)ethan-1-one<\/p>\n<\/td>\n

\n

1345970-43-5<\/p>\n<\/td>\n<\/tr>\n

\n

213<\/p>\n<\/td>\n

\n

CBL-018<\/p>\n<\/td>\n

\n

naphthalen-1-yl 1-pentyl-1H<\/i>-indole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

214<\/p>\n<\/td>\n

\n

CL-2201<\/p>\n<\/td>\n

\n

(4-chloronaphthalen-1-yl)(1-(5-fluoropentyl)-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

1391486-12-6<\/p>\n<\/td>\n<\/tr>\n

\n

215<\/p>\n<\/td>\n

\n

CP-47,497\u00a0<\/p>\n<\/td>\n

\n

rel-2-((1R,3S)-3-hydroxycyclohexyl)-5-(2-methyloctan-2-yl)phenol<\/p>\n<\/td>\n

\n

70434-82-1<\/p>\n<\/td>\n<\/tr>\n

\n

216<\/p>\n<\/td>\n

\n

CP-47,497 (C8 + C2)<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

217<\/p>\n<\/td>\n

\n

CP-47,497-C6<\/p>\n<\/td>\n

\n

rel-2-((1R,3S)-3-hydroxycyclohexyl)-5-(2-methylheptan-2-yl)phenol<\/p>\n<\/td>\n

\n

132296-20-9<\/p>\n<\/td>\n<\/tr>\n

\n

218<\/p>\n<\/td>\n

\n

CP-47,497-C8<\/p>\n

Cannabicyclohexanol<\/p>\n<\/td>\n

\n

rel-2-((1R,3S)-3-hydroxycyclohexyl)-5-(2-methylnonan-2-yl)phenol<\/p>\n<\/td>\n

\n

70434-92-3<\/p>\n<\/td>\n<\/tr>\n

\n

219<\/p>\n<\/td>\n

\n

CP-47,497-C9<\/p>\n<\/td>\n

\n

rel-2-((1R,3S)-3-hydroxycyclohexyl)-5-(2-methyldecan-2-yl)phenol<\/p>\n<\/td>\n

\n

132296-12-9<\/p>\n<\/td>\n<\/tr>\n

\n

220<\/p>\n<\/td>\n

\n

CP-55,244<\/p>\n<\/td>\n

\n

(2S,4S,4aS,6R,8aR)-4-(2-hydroxy-4-(2-methyloctan-2-yl)phenyl)-6-(hydroxymethyl)decahydronaphthalen-2-ol<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

221<\/p>\n<\/td>\n

\n

CP-55,940\u00a0<\/p>\n<\/td>\n

\n

rel-2-((1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl)-5-(2-methyloctan-2-yl)phenol<\/p>\n<\/td>\n

\n

83003-12-7<\/p>\n<\/td>\n<\/tr>\n

\n

222<\/p>\n<\/td>\n

\n

CRA-13<\/p>\n<\/td>\n

\n

naphthalen-1-yl(4-(pentyloxy)naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

432047-72-8<\/p>\n<\/td>\n<\/tr>\n

\n

223<\/p>\n<\/td>\n

\n

CUMYL-4CNBINACA<\/p>\n<\/td>\n

\n

1-(4-cyanobutyl)-N<\/i>-(1-methyl-1-phenyl-ethyl)indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

224<\/p>\n<\/td>\n

\n

CUMYL-5F-P7AICA<\/p>\n<\/td>\n

\n

1-(5-fluoropentyl)-N<\/i>-(2-phenylpropan-2-yl)-1H<\/i>-pyrrolo[2,3-b]pyridine-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

225<\/p>\n<\/td>\n

\n

CUMYL-5F
-PICACUMYL-5F-PICA<\/p>\n<\/td>\n

\n

1-(5-fluoropentyl)-N<\/i>-(2-phenylpropan-2-yl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

226<\/p>\n<\/td>\n

\n

CUMYL-5F-PINACACUMYL-5F-PINACA<\/p>\n<\/td>\n

\n

1-(5-fluoropentyl)-N<\/i>-(2-phenylpropan-2-yl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

227<\/p>\n<\/td>\n

\n

CUMYL-BICA<\/p>\n<\/td>\n

\n

1-butyl-N<\/i>-(2-phenylpropan-2-yl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

228<\/p>\n<\/td>\n

\n

CUMYL-PICA<\/p>\n<\/td>\n

\n

1-pentyl-N<\/i>-(2-phenylpropan-2-yl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

229<\/p>\n<\/td>\n

\n

CUMYL-PINACA<\/p>\n<\/td>\n

\n

1-pentyl-N<\/i>-(2-phenylpropan-2-yl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

230<\/p>\n<\/td>\n

\n

CUMYL-THPINACA<\/p>\n<\/td>\n

\n

N<\/i>-(2-phenylpropan-2-yl)-1-((tetrahydro-2H<\/i>-pyran-4-yl)methyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

231<\/p>\n<\/td>\n

\n

Dexamphetamine<\/p>\n<\/td>\n

\n

(+) \u2013 2 \u2013 amino \u2013 1 \u2013 phenylpropane<\/p>\n<\/td>\n

\n

51-64-9<\/p>\n<\/td>\n<\/tr>\n

\n

232<\/p>\n<\/td>\n

\n

Diethylpropion<\/p>\n<\/td>\n

\n

2-(Diethylamino) propiophenone<\/p>\n<\/td>\n

\n

90-84-6<\/p>\n<\/td>\n<\/tr>\n

\n

233<\/p>\n<\/td>\n

\n

Dimethyl CP-47,497-C8<\/p>\n<\/td>\n

\n

rel-2-((1R,5S)-5-hydroxy-3,3-dimethylcyclohexyl)-5-(2-methylnonan-2-yl)phenol<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

234<\/p>\n<\/td>\n

\n

EAM-2201<\/p>\n

(5F-JWH-210\u00a0)<\/p>\n<\/td>\n

\n

(4-ethylnaphthalen-1-yl)(1-(5-fluoropentyl)-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

1364933-60-7<\/p>\n<\/td>\n<\/tr>\n

\n

235<\/p>\n<\/td>\n

\n

EG-018<\/p>\n<\/td>\n

\n

naphthalen-1-yl(9-pentyl-9H<\/i>-carbazol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

236<\/p>\n<\/td>\n

\n

EG-2201<\/p>\n<\/td>\n

\n

(9-(5-fluoropentyl)-9H<\/i>-carbazol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

3652-90-2<\/p>\n<\/td>\n<\/tr>\n

\n

237<\/p>\n<\/td>\n

\n

EMB-FUBINACA<\/p>\n<\/td>\n

\n

ethyl (1-(4-fluorobenzyl)-1H<\/i>-indazole-3-carbonyl)valinate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

238<\/p>\n<\/td>\n

\n

Ethylone<\/p>\n<\/td>\n

\n

( RS ) -1- (1,3-benzodioxol-5-yl) -2- (ethylamino) propane-1-one<\/p>\n<\/td>\n

\n

1112937-64-0<\/p>\n<\/td>\n<\/tr>\n

\n

239<\/p>\n<\/td>\n

\n

Ethylphenidate<\/p>\n<\/td>\n

\n

( RS )-ethyl 2-phenyl-2-piperidin-2-yl acetate<\/p>\n<\/td>\n

\n

57413-43-1<\/p>\n<\/td>\n<\/tr>\n

\n

240<\/p>\n<\/td>\n

\n

FDU-NNEI<\/p>\n<\/td>\n

\n

1-(4-fluorobenzyl)-N<\/i>-(naphthalen-1-yl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

241<\/p>\n<\/td>\n

\n

FDU-PB-22<\/p>\n<\/td>\n

\n

naphthalen-1-yl 1-(4-fluorobenzyl)-1H<\/i>-indole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

242<\/p>\n<\/td>\n

\n

Fenethylline<\/p>\n<\/td>\n

\n

7 \u2013 [2 \u2013 (\u03b1<\/i> \u2013 methylphenethyl \u2013 amino) ethyl] theophylline<\/p>\n<\/td>\n

\n

3736-08-1<\/p>\n<\/td>\n<\/tr>\n

\n

243<\/p>\n<\/td>\n

\n

FUB-144 (FUB-UR-144)<\/p>\n<\/td>\n

\n

[1-(4-fluorobenzyl)-1H<\/i>-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

244<\/p>\n<\/td>\n

\n

FUB-AKB-48<\/p>\n<\/td>\n

\n

N<\/i>-((3s,5s,7s)-adamantan-1-yl)-1-(4-fluorobenzyl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

245<\/p>\n<\/td>\n

\n

FUB-AMB<\/p>\n<\/td>\n

\n

methyl (1-(4-fluorobenzyl)-1H<\/i>-indazole-3-carbonyl)valinate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

246<\/p>\n<\/td>\n

\n

FUBIMINA<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-1H<\/i>-benzo[d]imidazol-2-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

247<\/p>\n<\/td>\n

\n

FUB-JWH-018<\/p>\n<\/td>\n

\n

(1-(4-fluorobenzyl)-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

248<\/p>\n<\/td>\n

\n

FUB-PB-22<\/p>\n<\/td>\n

\n

quinolin-8-yl 1-(4-fluorobenzyl)-1H<\/i>-indole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

249<\/p>\n<\/td>\n

\n

Furanylfentanyl<\/p>\n<\/td>\n

\n

N<\/i>-Phenyl-N<\/i>-[1-(2-phenylethyl)piperidin- 4-yl]furan-2-carboxamide<\/p>\n<\/td>\n

\n

101345-66-8<\/p>\n<\/td>\n<\/tr>\n

\n

250<\/p>\n<\/td>\n

\n

GHB<\/p>\n<\/td>\n

\n

\u03b3-<\/i>Hydroxybutyric acid<\/p>\n<\/td>\n

\n

591-81-1<\/p>\n<\/td>\n<\/tr>\n

\n

251<\/p>\n<\/td>\n

\n

HU-210<\/p>\n<\/td>\n

\n

(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H<\/i>-benzo[c]chromen-1-ol<\/p>\n<\/td>\n

\n

112830-95-2<\/p>\n<\/td>\n<\/tr>\n

\n

252<\/p>\n<\/td>\n

\n

HU-211<\/p>\n<\/td>\n

\n

(6a,10a)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H<\/i>-benzo[c]chromen-1-ol<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

253<\/p>\n<\/td>\n

\n

HU-308<\/p>\n<\/td>\n

\n

(4-(2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl)-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl)methanol<\/p>\n<\/td>\n

\n

256934-39-1<\/p>\n<\/td>\n<\/tr>\n

\n

254<\/p>\n<\/td>\n

\n

HU-331<\/p>\n<\/td>\n

\n

(1\u2019R)-6-hydroxy-3\u2032-methyl-4-pentyl-6\u2032-(prop-1-en-2-yl)-[1,1\u2032-bi(cyclohexane)]-2\u2032,3,6-triene-2,5-dione<\/p>\n<\/td>\n

\n

137252-25-6<\/p>\n<\/td>\n<\/tr>\n

\n

255<\/p>\n<\/td>\n

\n

INPB-22<\/p>\n<\/td>\n

\n

quinolin-8-yl 1-pentyl-1H<\/i>-indazole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

256<\/p>\n<\/td>\n

\n

JTE-907\u00a0<\/p>\n<\/td>\n

\n

N<\/i>-(benzo[d][1,3]dioxol-5-ylmethyl)-7-methoxy-2-oxo-8-(pentyloxy)-1,2-dihydroquinoline-3-carboxamide<\/p>\n<\/td>\n

\n

282089-49-0<\/p>\n<\/td>\n<\/tr>\n

\n

257<\/p>\n<\/td>\n

\n

JWH-007<\/p>\n<\/td>\n

\n

(2-methyl-1-pentyl-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

155471-10-6<\/p>\n<\/td>\n<\/tr>\n

\n

258<\/p>\n<\/td>\n

\n

JWH-015<\/p>\n<\/td>\n

\n

(2-methyl-1-propyl-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

155471-08-2<\/p>\n<\/td>\n<\/tr>\n

\n

259<\/p>\n<\/td>\n

\n

JWH-018<\/p>\n<\/td>\n

\n

1-pentyl-3-(1-naphthoyl) indole<\/p>\n<\/td>\n

\n

209414-07-3<\/p>\n<\/td>\n<\/tr>\n

\n

260<\/p>\n<\/td>\n

\n

JWH-018 adamantyl<\/p>\n

(AB-001)<\/p>\n<\/td>\n

\n

adamantan-1-yl(1-pentyl-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

261<\/p>\n<\/td>\n

\n

JWH-018
cyclohexylmethyl<\/p>\n<\/td>\n

\n

(1-(cyclohexylmethyl)-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

262<\/p>\n<\/td>\n

\n

JWH-018 isopentyl<\/p>\n<\/td>\n

\n

(1-isopentyl-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

263<\/p>\n<\/td>\n

\n

JWH-018 N-(5-bromopentyl)<\/p>\n<\/td>\n

\n

(1-(5-bromopentyl)-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

264<\/p>\n<\/td>\n

\n

JWH-018 N-(5-chloropentyl)\u00a0<\/p>\n<\/td>\n

\n

(1-(5-chloropentyl)-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

265<\/p>\n<\/td>\n

\n

JWH-018 N-(5-hydroxypentyl)<\/p>\n<\/td>\n

\n

(1-(5-hydroxypentyl)-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

266<\/p>\n<\/td>\n

\n

JWH-019\u00a0<\/p>\n<\/td>\n

\n

(1-hexyl-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

209414-08-4<\/p>\n<\/td>\n<\/tr>\n

\n

267<\/p>\n<\/td>\n

\n

JWH-022\u00a0<\/p>\n<\/td>\n

\n

naphthalen-1-yl(1-(pent-4-en-1-yl)-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

209414-16-4<\/p>\n<\/td>\n<\/tr>\n

\n

268<\/p>\n<\/td>\n

\n

JWH-030<\/p>\n<\/td>\n

\n

naphthalen-1-yl(1-pentyl-1H<\/i>-pyrrol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

269<\/p>\n<\/td>\n

\n

JWH-071<\/p>\n<\/td>\n

\n

(1-ethyl-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

270<\/p>\n<\/td>\n

\n

JWH-073<\/p>\n<\/td>\n

\n

1-butyl-3-(1-naphthoyl) indole<\/p>\n<\/td>\n

\n

208987-48-8<\/p>\n<\/td>\n<\/tr>\n

\n

271<\/p>\n<\/td>\n

\n

JWH-073 (4-methylnaphthyl)<\/p>\n<\/td>\n

\n

(1-butyl-1H<\/i>-indol-3-yl)(4-methylnaphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

272<\/p>\n<\/td>\n

\n

JWH-081\u00a0<\/p>\n<\/td>\n

\n

(4-methoxynaphthalen-1-yl)(1-pentyl-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

210179-46-7<\/p>\n<\/td>\n<\/tr>\n

\n

273<\/p>\n<\/td>\n

\n

JWH-122\u00a0<\/p>\n<\/td>\n

\n

(4-methylnaphthalen-1-yl)(1-pentyl-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

619294-47-2<\/p>\n<\/td>\n<\/tr>\n

\n

274<\/p>\n<\/td>\n

\n

JWH-122 5-
Methyl-naphtyl<\/p>\n<\/td>\n

\n

(5-methylnaphthalen-1-yl)(1-pentyl-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

275<\/p>\n<\/td>\n

\n

JWH-122 N-(4-pentenyl)\u00a0<\/p>\n<\/td>\n

\n

(4-methylnaphthalen-1-yl)(1-(pent-4-en-1-yl)-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

1445577-68-3<\/p>\n<\/td>\n<\/tr>\n

\n

276<\/p>\n<\/td>\n

\n

JWH-122 N-(4-pentenyl)
-2-methylindole<\/p>\n<\/td>\n

\n

(4-methylnaphthalen-1-yl)(1-(4-pentenyl) -2-methylindole)-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

277<\/p>\n<\/td>\n

\n

JWH-122 N-(5-chloropentyl)<\/p>\n<\/td>\n

\n

(1-(5-chloropentyl)-1H<\/i>-indol-3-yl)(4-methylnaphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

278<\/p>\n<\/td>\n

\n

JWH-122 N-(5-hydroxypentyl)<\/p>\n<\/td>\n

\n

(1-(5-hydroxypentyl)-1H<\/i>-indol-3-yl)(4-methylnaphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

279<\/p>\n<\/td>\n

\n

JWH-145<\/p>\n<\/td>\n

\n

naphthalen-1-yl(1-pentyl-5-phenyl-1H<\/i>-pyrrol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

280<\/p>\n<\/td>\n

\n

JWH-175<\/p>\n<\/td>\n

\n

(1-pentylindol-3-yl)naphthalen-1-ylmethane<\/p>\n<\/td>\n

\n

619294-35-8<\/p>\n<\/td>\n<\/tr>\n

\n

281<\/p>\n<\/td>\n

\n

JWH-182<\/p>\n<\/td>\n

\n

(1-pentyl-1H<\/i>-indol-3-yl)(4-propylnaphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

824960-02-3<\/p>\n<\/td>\n<\/tr>\n

\n

282<\/p>\n<\/td>\n

\n

JWH-200<\/p>\n<\/td>\n

\n

(1-(2-morpholinoethyl)-1H<\/i>-indol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

103610-04-4<\/p>\n<\/td>\n<\/tr>\n

\n

283<\/p>\n<\/td>\n

\n

JWH-201<\/p>\n<\/td>\n

\n

2-(4-methoxyphenyl)-1-(1-pentyl-1H<\/i>-indol-3-yl)ethan-1-one<\/p>\n<\/td>\n

\n

864445-47-6<\/p>\n<\/td>\n<\/tr>\n

\n

284<\/p>\n<\/td>\n

\n

JWH-203<\/p>\n<\/td>\n

\n

2-(2-chlorophenyl)-1-(1-pentyl-1H<\/i>-indol-3-yl)ethan-1-one<\/p>\n<\/td>\n

\n

864445-54-5<\/p>\n<\/td>\n<\/tr>\n

\n

285<\/p>\n<\/td>\n

\n

JWH-206<\/p>\n<\/td>\n

\n

2-(4-chlorophenyl)-1-(1-pentyl-1H<\/i>-indol-3-yl)ethan-1-one<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

286<\/p>\n<\/td>\n

\n

JWH-210<\/p>\n<\/td>\n

\n

(4-ethylnaphthalen-1-yl)(1-pentyl-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

824959-81-1<\/p>\n<\/td>\n<\/tr>\n

\n

287<\/p>\n<\/td>\n

\n

JWH-213<\/p>\n<\/td>\n

\n

(4-ethylnaphthalen-1-yl)(2-methyl-1-pentyl-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

824959-83-3<\/p>\n<\/td>\n<\/tr>\n

\n

288<\/p>\n<\/td>\n

\n

JWH-250<\/p>\n<\/td>\n

\n

1-pentyl-3- (2-methoxyphenylacetyl) indole<\/p>\n<\/td>\n

\n

864445-43-2<\/p>\n<\/td>\n<\/tr>\n

\n

289<\/p>\n<\/td>\n

\n

JWH-251<\/p>\n<\/td>\n

\n

1-(1-pentyl-1H<\/i>-indol-3-yl)-2-(o-tolyl)ethan-1-one<\/p>\n<\/td>\n

\n

864445-39-6<\/p>\n<\/td>\n<\/tr>\n

\n

290<\/p>\n<\/td>\n

\n

JWH-267<\/p>\n<\/td>\n

\n

(2-methoxynaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

291<\/p>\n<\/td>\n

\n

JWH-302<\/p>\n<\/td>\n

\n

2-(3-methoxyphenyl)-1-(1-pentyl-1H<\/i>-indol-3-yl)ethan-1-one<\/p>\n<\/td>\n

\n

864445-45-4<\/p>\n<\/td>\n<\/tr>\n

\n

292<\/p>\n<\/td>\n

\n

JWH-307<\/p>\n<\/td>\n

\n

(5-(2-fluorophenyl)-1-pentyl-1H<\/i>-pyrrol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

914458-26-7<\/p>\n<\/td>\n<\/tr>\n

\n

293<\/p>\n<\/td>\n

\n

JWH-368<\/p>\n<\/td>\n

\n

(5-(3-fluorophenyl)-1-pentyl-1H<\/i>-pyrrol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

914458-31-4<\/p>\n<\/td>\n<\/tr>\n

\n

294<\/p>\n<\/td>\n

\n

JWH-370<\/p>\n<\/td>\n

\n

naphthalen-1-yl(1-pentyl-5-(o-tolyl)-1H<\/i>-pyrrol-3-yl)methanone<\/p>\n<\/td>\n

\n

914458-22-3<\/p>\n<\/td>\n<\/tr>\n

\n

295<\/p>\n<\/td>\n

\n

JWH-387<\/p>\n<\/td>\n

\n

(4-bromonaphthalen-1-yl)(1-pentyl-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

207227-49-4<\/p>\n<\/td>\n<\/tr>\n

\n

296<\/p>\n<\/td>\n

\n

JWH-398<\/p>\n<\/td>\n

\n

(4-chloronaphthalen-1-yl)(1-pentyl-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

1292765-18-4<\/p>\n<\/td>\n<\/tr>\n

\n

297<\/p>\n<\/td>\n

\n

JWH-412<\/p>\n<\/td>\n

\n

(4-fluoronaphthalen-1-yl)(1-pentyl-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

298<\/p>\n<\/td>\n

\n

JWH-412 N-(-5-fluoropentyl)<\/p>\n<\/td>\n

\n

(4-fluoronaphthalen-1-yl)(1-(5-fluoropentyl)-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

299<\/p>\n<\/td>\n

\n

Levamphetamine<\/p>\n<\/td>\n

\n

1 \u2013\u00a0 \u03b1<\/i> \u2013 methylphenethylamine<\/p>\n<\/td>\n

\n

156-34-3<\/p>\n<\/td>\n<\/tr>\n

\n

300<\/p>\n<\/td>\n

\n

Levomethamphetamine<\/p>\n<\/td>\n

\n

(-) \u2013 N<\/i>, \u03b1<\/i> \u2013 dimethylphenethylamine<\/p>\n<\/td>\n

\n

537-46-2<\/p>\n<\/td>\n<\/tr>\n

\n

301<\/p>\n<\/td>\n

\n

LS-91297<\/p>\n<\/td>\n

\n

(4-methoxyphenyl)(1-methyl-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

302<\/p>\n<\/td>\n

\n

LTI-701<\/p>\n<\/td>\n

\n

1-(5-fluoropentyl)-N<\/i>-phenyl-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

303<\/p>\n<\/td>\n

\n

LY-2183240<\/p>\n<\/td>\n

\n

5-([1,1\u2032-biphenyl]-4-ylmethyl)-N<\/i>,N<\/i>-dimethyl-1H<\/i>-tetrazole-1-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

304<\/p>\n<\/td>\n

\n

LY2183240-2\u2032-isomer<\/p>\n<\/td>\n

\n

5-([1,1\u2032-biphenyl]-4-ylmethyl)-N<\/i>,N<\/i>-dimethyl-2H<\/i>-tetrazole-2-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

305<\/p>\n<\/td>\n

\n

M5FPIC<\/p>\n<\/td>\n

\n

methyl 1-(5-fluoropentyl)-1H<\/i>-indole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

306<\/p>\n<\/td>\n

\n

MAM-2201<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-1H<\/i>-indol-3-yl)(4-methylnaphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

1354631-24-5<\/p>\n<\/td>\n<\/tr>\n

\n

307<\/p>\n<\/td>\n

\n

MAM-2201 N-(2-Fluoropentyl)<\/p>\n<\/td>\n

\n

(1-(2-fluoropentyl)-1H<\/i>-indol-3-yl)(4-methylnaphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

308<\/p>\n<\/td>\n

\n

MAM-2201 N-(3-Fluoropentyl)<\/p>\n<\/td>\n

\n

(1-(3-fluoropentyl)-1H<\/i>-indol-3-yl)(4-methylnaphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

309<\/p>\n<\/td>\n

\n

MAM-2201 N-(4-Fluoropentyl)<\/p>\n<\/td>\n

\n

(1-(4-fluoropentyl)-1H<\/i>-indol-3-yl)(4-methylnaphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

310<\/p>\n<\/td>\n

\n

MAM-2201 N-(4-hydroxypentyl)<\/p>\n<\/td>\n

\n

(1-(4-hydroxypentyl)-1H<\/i>-indol-3-yl)(4-methylnaphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

311<\/p>\n<\/td>\n

\n

M-CHMIC<\/p>\n<\/td>\n

\n

methyl 1-(cyclohexylmethyl)-1H<\/i>-indole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

312<\/p>\n<\/td>\n

\n

MCPP (m<\/i>CPP)<\/p>\n<\/td>\n

\n

Meta \u2013<\/i> Chlorophenyl piperazine<\/p>\n<\/td>\n

\n

6640-24-0<\/p>\n<\/td>\n<\/tr>\n

\n

313<\/p>\n<\/td>\n

\n

MDMB-CHMCZCA<\/p>\n<\/td>\n

\n

methyl 2-(9-(cyclohexylmethyl)-9H<\/i>-carbazole-3-carboxamido)-3,3-dimethylbutanoate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

314<\/p>\n<\/td>\n

\n

MDMB-CHMICA<\/p>\n<\/td>\n

\n

methyl (S)-2-(1-(cyclohexylmethyl)-1H<\/i>-indole-3-carboxamido)-3,3-dimethylbutanoate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

315<\/p>\n<\/td>\n

\n

MDMB-CHMINACA\u00a0<\/p>\n<\/td>\n

\n

methyl 2-(1-(cyclohexylmethyl)-1H<\/i>-indazole-3-carboxamido)-3,3-dimethylbutanoate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

316<\/p>\n<\/td>\n

\n

MDMB-FUBICA<\/p>\n<\/td>\n

\n

Methyl 2-(1-(4-fluorobenzyl)-1H<\/i>-indol-3-carboxamido)-3,3-dimethylbutanoate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

317<\/p>\n<\/td>\n

\n

MDMB-FUBINACA<\/p>\n<\/td>\n

\n

methyl 2-(1-(4-fluorobenzyl)-1H<\/i>-indazole-3-carboxamido)-3,3-dimethylbutanoate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

318<\/p>\n<\/td>\n

\n

MDPBP<\/p>\n<\/td>\n

\n

(RS)-<\/i>1-(3,4-methylenedioxyphenyl)-2-(1-pyrrolidinyl)-1-butanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

319<\/p>\n<\/td>\n

\n

MDPV<\/p>\n<\/td>\n

\n

(RS<\/i>)-1-(benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one<\/p>\n<\/td>\n

\n

687603-66-3<\/p>\n<\/td>\n<\/tr>\n

\n

320<\/p>\n<\/td>\n

\n

Mecloqualone<\/p>\n<\/td>\n

\n

3 \u2013 (o<\/i> \u2013 chlorophenyl) \u2013 2 \u2013 methyl \u2013 4 \u2013 (3H<\/i>) \u2013 quinazolinone<\/p>\n<\/td>\n

\n

340-57-8<\/p>\n<\/td>\n<\/tr>\n

\n

321<\/p>\n<\/td>\n

\n

Mephedrone<\/p>\n<\/td>\n

\n

4-\u00a0methyl\u00a0methcathinone<\/p>\n<\/td>\n

\n

1189805-46-6<\/p>\n<\/td>\n<\/tr>\n

\n

322<\/p>\n<\/td>\n

\n

Mepirapim<\/p>\n<\/td>\n

\n

(4-methylpiperazin-1-yl)(1-pentyl-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

323<\/p>\n<\/td>\n

\n

Methamphetamine<\/p>\n<\/td>\n

\n

(+) \u2013 (S<\/i>) \u2013 N<\/i> \u2013 \u03b1<\/i> \u2013 dimethylphenethylamine<\/p>\n<\/td>\n

\n

537-46-2<\/p>\n<\/td>\n<\/tr>\n

\n

324<\/p>\n<\/td>\n

\n

Methamphetamine racemate<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 N<\/i>, \u03b1<\/i> \u2013 dimethylphenethylamine<\/p>\n<\/td>\n

\n

7632-10-2<\/p>\n<\/td>\n<\/tr>\n

\n

325<\/p>\n<\/td>\n

\n

Methaqualone<\/p>\n<\/td>\n

\n

2 \u2013 methyl \u2013 3 \u2013 o<\/i> \u2013 tolyl \u2013 4 \u2013 (3H<\/i>) \u2013 quinazolinone<\/p>\n<\/td>\n

\n

72-44-6<\/p>\n<\/td>\n<\/tr>\n

\n

326<\/p>\n<\/td>\n

\n

Methoxetamine<\/p>\n

(MXE)<\/p>\n<\/td>\n

\n

2-(3-methoxyphenyl)-2-(ethylamino)-cyclohexanone<\/p>\n<\/td>\n

\n

1239943-76-0<\/p>\n<\/td>\n<\/tr>\n

\n

327<\/p>\n<\/td>\n

\n

Methylone<\/p>\n<\/td>\n

\n

3,4 \u2013 methylenedioxy \u2013 N<\/i> \u2013 methylcathinone<\/p>\n<\/td>\n

\n

186028-79-5<\/p>\n<\/td>\n<\/tr>\n

\n

328<\/p>\n<\/td>\n

\n

MMB-018<\/p>\n<\/td>\n

\n

methyl (1-pentyl-1H<\/i>-indole-3-carbonyl)-L-valinate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

329<\/p>\n<\/td>\n

\n

MMB-PICA<\/p>\n<\/td>\n

\n

methyl (1-pentyl-1H<\/i>-indole-3-carbonyl)valinate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

330<\/p>\n<\/td>\n

\n

MMB-PINACA<\/p>\n<\/td>\n

\n

methyl (1-pentyl-1H<\/i>-indazole-3-carbonyl)valinate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

331<\/p>\n<\/td>\n

\n

MN-18<\/p>\n<\/td>\n

\n

N<\/i>-(naphthalen-1-yl)-1-pentyl-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

332<\/p>\n<\/td>\n

\n

MN-24<\/p>\n

(AM-6527; NNE1)<\/p>\n<\/td>\n

\n

N<\/i>-(naphthalen-1-yl)-1-pentyl-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

1338925-11-3<\/p>\n<\/td>\n<\/tr>\n

\n

333<\/p>\n<\/td>\n

\n

MO-CHMINACA<\/p>\n<\/td>\n

\n

1-methoxy-3,3-dimethyl-1-oxobutan-2-yl 1-(cyclohexylmethyl)-1H<\/i>-indazole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

334<\/p>\n<\/td>\n

\n

MPA<\/p>\n

(Methiopropamine)<\/p>\n<\/td>\n

\n

1- (thiophen-2-yl) -2-methylaminopropane<\/p>\n<\/td>\n

\n

801156-47-8<\/p>\n<\/td>\n<\/tr>\n

\n

335<\/p>\n<\/td>\n

\n

MT-45<\/p>\n<\/td>\n

\n

1-xyclohexyl-4 (1,2-diphenylethyl) piperazine<\/p>\n<\/td>\n

\n

52694-55-0<\/p>\n<\/td>\n<\/tr>\n

\n

336<\/p>\n<\/td>\n

\n

N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(phenylmethyl)-1H-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-benzyl-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

337<\/p>\n<\/td>\n

\n

N-(1-Amino-3-methyl-1oxobutan-2-yl)-1-(phenylmethyl)-1H-indole-3-carboxamide<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-3-methyl-1-oxobutan-2-yl)-1-benzyl-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

338<\/p>\n<\/td>\n

\n

N-(2-Methoxyethyl)-N-(1-methylethyl)-2-(1-pentyl-1H-indol-3-yl)-4-thiazol-methanamine<\/p>\n<\/td>\n

\n

N-(2-methoxyethyl)-N<\/i>-((2-(1-pentyl-1H<\/i>-indol-3-yl)thiazol-4-yl)methyl)propan-2-amine<\/p>\n<\/td>\n

\n

1400742-45-1<\/p>\n<\/td>\n<\/tr>\n

\n

339<\/p>\n<\/td>\n

\n

N-(6-Quinolinyl)-1-pentyl-1H-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

1-pentyl-N<\/i>-(quinolin-6-yl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

340<\/p>\n<\/td>\n

\n

N-(Naphthalen-1-yl)-
1H-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

N<\/i>-(naphthalen-1-yl)-1H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

341<\/p>\n<\/td>\n

\n

N-(naphthalen-1-yl)-1-pentyl-1H-pyrrolo
[2,3-b]pyridine-3-carboxamide<\/p>\n<\/td>\n

\n

N<\/i>-(naphthalen-1-yl)-1-pentyl-1H<\/i>-pyrrolo[2,3-b]pyridine-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

342<\/p>\n<\/td>\n

\n

N,N-Diethyl-2-
(1-pentyl-1H-indol-3-yl)-4-thiazol-methanamine\u00a0<\/p>\n<\/td>\n

\n

N<\/i>-ethyl-N<\/i>-((2-(1-pentyl-1H<\/i>-indol-3-yl)thiazol-4-yl)methyl)ethanamine<\/p>\n<\/td>\n

\n

1400742-46-2<\/p>\n<\/td>\n<\/tr>\n

\n

343<\/p>\n<\/td>\n

\n

Naphthalen-1-yl(1-(pent-4-enyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)
methanone<\/p>\n<\/td>\n

\n

naphthalen-1-yl(1-(pent-4-en-1-yl)-1H<\/i>-pyrrolo[2,3-b]pyridin-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

344<\/p>\n<\/td>\n

\n

Naphthalen-1-yl(1-(pentyl-1H-benzo[d]imidazol-2-yl)methanone<\/p>\n<\/td>\n

\n

naphthalen-1-yl(1-pentyl-1H<\/i>-benzo[d]imidazol-2-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

345<\/p>\n<\/td>\n

\n

Naphthalen-1-yl-
(1-pentyl-1H-7-azaindol-3-yl)methanone<\/p>\n<\/td>\n

\n

Naphthalen-1-yl-(1-pentyl-1H<\/i>-7-azaindol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

346<\/p>\n<\/td>\n

\n

Naphthalen-1-yl-1-
benzyl-1H-indole-3-carboxylate<\/p>\n<\/td>\n

\n

naphthalen-1-yl 1-benzyl-1H<\/i>-indole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

347<\/p>\n<\/td>\n

\n

NM-2201<\/p>\n<\/td>\n

\n

naphthalen-1-yl 1-(5-fluoropentyl)-1H<\/i>-indole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

348<\/p>\n<\/td>\n

\n

NNEI 2\u2019-indazole isomer<\/p>\n<\/td>\n

\n

N<\/i>-(naphthalen-1-yl)-2-pentyl-2H<\/i>-indazole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

349<\/p>\n<\/td>\n

\n

ORG 27569<\/p>\n<\/td>\n

\n

5-chloro-3-ethyl-N<\/i>-(4-(piperidin-1-yl)phenethyl)-1H<\/i>-indole-2-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

350<\/p>\n<\/td>\n

\n

ORG 27759<\/p>\n<\/td>\n

\n

N<\/i>-(4-(dimethylamino)phenethyl)-3-ethyl-5-fluoro-1H<\/i>-indole-2-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

351<\/p>\n<\/td>\n

\n

ORG 29647<\/p>\n<\/td>\n

\n

N<\/i>-(1-benzylpyrrolidin-3-yl)-5-chloro-3-ethyl-1H<\/i>-indole-2-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

352<\/p>\n<\/td>\n

\n

PB-22<\/p>\n

(QUPIC)<\/p>\n<\/td>\n

\n

quinolin-8-yl 1-pentyl-1H<\/i>-indole-3-carboxylate<\/p>\n<\/td>\n

\n

1400742-17-7<\/p>\n<\/td>\n<\/tr>\n

\n

353<\/p>\n<\/td>\n

\n

PB-22 N-(2-fluoropentyl)<\/p>\n<\/td>\n

\n

quinolin-8-yl 1-(2-fluoropentyl)-1H<\/i>-indazole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

354<\/p>\n<\/td>\n

\n

PB-22 N-(4-fluoropentyl)<\/p>\n<\/td>\n

\n

quinolin-8-yl 1-(4-fluoropentyl)-1H<\/i>-indazole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

355<\/p>\n<\/td>\n

\n

Pentedrone<\/p>\n<\/td>\n

\n

(\u00b1) -1-phenyl-2- (metylamino) pentan-1-one<\/p>\n<\/td>\n

\n

879722-57-3<\/p>\n<\/td>\n<\/tr>\n

\n

356<\/p>\n<\/td>\n

\n

Phencyclidine<\/p>\n<\/td>\n

\n

1 \u2013 (1 \u2013 phenylcyclohexyl) piperidine<\/p>\n<\/td>\n

\n

77-10-1<\/p>\n<\/td>\n<\/tr>\n

\n

357<\/p>\n<\/td>\n

\n

Phenezepam<\/p>\n<\/td>\n

\n

7-Bromo-5- (2-clophenyl) -1,3-dihydro-2 H<\/i> -1,4-benzodiazepine-2-one<\/p>\n<\/td>\n

\n

51753-57-2<\/p>\n<\/td>\n<\/tr>\n

\n

358<\/p>\n<\/td>\n

\n

Phenmetrazine<\/p>\n<\/td>\n

\n

3 \u2013 methyl \u2013 2 \u2013 phenylmorpholine<\/p>\n<\/td>\n

\n

134-49-6<\/p>\n<\/td>\n<\/tr>\n

\n

359<\/p>\n<\/td>\n

\n

Pholcodine<\/p>\n<\/td>\n

\n

3 \u2013 morpholinylethylmorphine<\/p>\n<\/td>\n

\n

509-67-1<\/p>\n<\/td>\n<\/tr>\n

\n

360<\/p>\n<\/td>\n

\n

Pravadoline<\/p>\n

(WIN 48,098)<\/p>\n<\/td>\n

\n

(4-methoxyphenyl)(2-methyl-1-(2-morpholinoethyl)-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

92623-83-1<\/p>\n<\/td>\n<\/tr>\n

\n

361<\/p>\n<\/td>\n

\n

PX-1<\/p>\n<\/td>\n

\n

N<\/i>-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

362<\/p>\n<\/td>\n

\n

QUCHIC<\/p>\n

(BB-22)<\/p>\n<\/td>\n

\n

quinolin-8-yl 1-(cyclohexylmethyl)-1H<\/i>-indole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

363<\/p>\n<\/td>\n

\n

Quinolin-8-yl-1-benzyl-1H<\/i>-indazole-3-carboxylate<\/p>\n<\/td>\n

\n

quinolin-8-yl 1-benzyl-1H<\/i>-indazole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

364<\/p>\n<\/td>\n

\n

RCS-2 butyl<\/p>\n<\/td>\n

\n

1-butyl-2-(2-methoxyphenyl)-1H<\/i>-indole-3-carbaldehyde<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

365<\/p>\n<\/td>\n

\n

RCS-3<\/p>\n<\/td>\n

\n

2-(3-methoxyphenyl)-1-(1-pentyl-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

366<\/p>\n<\/td>\n

\n

RCS-4<\/p>\n<\/td>\n

\n

(4-methoxyphenyl)(1-pentyl-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

1345966-78-0<\/p>\n<\/td>\n<\/tr>\n

\n

367<\/p>\n<\/td>\n

\n

RCS-4 butyl<\/p>\n<\/td>\n

\n

(4-methoxyphenyl)(1-butyl-1H<\/i>-indol-3-yl) methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

368<\/p>\n<\/td>\n

\n

RCS-4 ortho isomer<\/p>\n<\/td>\n

\n

(2-methoxyphenyl)(1-pentyl-1H<\/i>-indol-3-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

369<\/p>\n<\/td>\n

\n

RCS-8<\/p>\n

(SR-18; BTM-8)<\/p>\n<\/td>\n

\n

1-(1-(2-cyclohexylethyl)-1H<\/i>-indol-3-yl)-2-(2-methoxyphenyl)ethan-1-one<\/p>\n<\/td>\n

\n

1345970-42-4<\/p>\n<\/td>\n<\/tr>\n

\n

370<\/p>\n<\/td>\n

\n

Rimonabant<\/p>\n<\/td>\n

\n

5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H<\/i>-pyrazole-3-carboxamide<\/p>\n<\/td>\n

\n

168273-06-1<\/p>\n<\/td>\n<\/tr>\n

\n

371<\/p>\n<\/td>\n

\n

SDB-005<\/p>\n<\/td>\n

\n

naphthalen-1-yl 1-pentyl-1H<\/i>-indazole-3-carboxylate<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

372<\/p>\n<\/td>\n

\n

SDB-006<\/p>\n<\/td>\n

\n

N<\/i>-benzyl-1-pentyl-1H<\/i>-indole-3-carboxamide<\/p>\n<\/td>\n

\n

695213-59-3<\/p>\n<\/td>\n<\/tr>\n

\n

373<\/p>\n<\/td>\n

\n

Secobarbital<\/p>\n<\/td>\n

\n

5 \u2013 ally \u2013 5 \u2013 (1 \u2013 methylbutyl) barbituric acid<\/p>\n<\/td>\n

\n

76-73-3<\/p>\n<\/td>\n<\/tr>\n

\n

374<\/p>\n<\/td>\n

\n

TFMPP<\/p>\n<\/td>\n

\n

1[3-(trifluoromethyl) phenyl] piperazine<\/p>\n<\/td>\n

\n

15532-75-9<\/p>\n<\/td>\n<\/tr>\n

\n

375<\/p>\n<\/td>\n

\n

THJ-018<\/p>\n<\/td>\n

\n

naphthalen-1-yl(1-pentyl-1H<\/i>-indazol-3-yl)methanone<\/p>\n<\/td>\n

\n

1364933-55-0<\/p>\n<\/td>\n<\/tr>\n

\n

376<\/p>\n<\/td>\n

\n

THJ-2201<\/p>\n<\/td>\n

\n

(1-(5-fluoropentyl)-1H<\/i>-indazol-3-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

377<\/p>\n<\/td>\n

\n

Tramadol<\/p>\n<\/td>\n

\n

(\u00b1)-Trans-2-Dimethylaminomethyl-1-(3-methoxyphenyl) cyclohexan-1-ol<\/p>\n<\/td>\n

\n

27203-92-5<\/p>\n<\/td>\n<\/tr>\n

\n

378<\/p>\n<\/td>\n

\n

Trans-CP 47,497-C8<\/p>\n<\/td>\n

\n

2-[(1S,3S)-3-hydroxycyclohexyl]-5-(2-methylnonan-2-yl)phenol<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

379<\/p>\n<\/td>\n

\n

U-47700<\/p>\n<\/td>\n

\n

3,4-dichloro-N<\/i>-[(1R,2R)-2 -(dimetylamino)cyclohexyl]-N<\/i>\u2013 methyl-benzamide<\/p>\n<\/td>\n

\n

82657-23-6<\/p>\n<\/td>\n<\/tr>\n

\n

380<\/p>\n<\/td>\n

\n

UR-144<\/p>\n

(KM-X1)<\/p>\n<\/td>\n

\n

(1-pentyl-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone<\/p>\n<\/td>\n

\n

1199943-44-6<\/p>\n<\/td>\n<\/tr>\n

\n

381<\/p>\n<\/td>\n

\n

UR-144 N-
(3-chloropentyl)<\/p>\n<\/td>\n

\n

(1-(3-chloropentyl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

382<\/p>\n<\/td>\n

\n

UR-144 N-(4-pentenyl)<\/p>\n<\/td>\n

\n

(1-(pent-4-en-1-yl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

383<\/p>\n<\/td>\n

\n

UR-144 N-
(5-bromopentyl)<\/p>\n<\/td>\n

\n

(1-(5-bromopentyl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

384<\/p>\n<\/td>\n

\n

UR-144 N-
(5-chlomopentyl)<\/p>\n<\/td>\n

\n

(1-(5-chloropentyl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

385<\/p>\n<\/td>\n

\n

UR-144 N-heptyl<\/p>\n<\/td>\n

\n

(1-heptyl-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

386<\/p>\n<\/td>\n

\n

URB447<\/p>\n<\/td>\n

\n

(4-amino-1-(4-chlorobenzyl)-2-methyl-5-phenyl-1H<\/i>-pyrrol-3-yl)(phenyl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

387<\/p>\n<\/td>\n

\n

URB597<\/p>\n<\/td>\n

\n

(3\u2032-carbamoyl-[1,1\u2032-biphenyl]-3-yl)(cyclohexyl)carbamate<\/p>\n<\/td>\n

\n

546141-08-6<\/p>\n<\/td>\n<\/tr>\n

\n

388<\/p>\n<\/td>\n

\n

URB-602<\/p>\n<\/td>\n

\n

cyclohexyl [1,1\u2032-biphenyl]-3-ylcarbamate<\/p>\n<\/td>\n

\n

565460-15-3<\/p>\n<\/td>\n<\/tr>\n

\n

389<\/p>\n<\/td>\n

\n

URB754\u00a0<\/p>\n<\/td>\n

\n

6-methyl-2-(p-tolylamino)-4H<\/i>-benzo[d][1,3]oxazin-4-one<\/p>\n<\/td>\n

\n

86672-58-4<\/p>\n<\/td>\n<\/tr>\n

\n

390<\/p>\n<\/td>\n

\n

WIN 55, 212-2<\/p>\n<\/td>\n

\n

(R)-(5-methyl-3-(morpholinomethyl)-2,3-dihydro-[1,4]oxazino[2,3,4-hi]indol-6-yl)(naphthalen-1-yl)methanone<\/p>\n<\/td>\n

\n

131543-23-2<\/p>\n<\/td>\n<\/tr>\n

\n

391<\/p>\n<\/td>\n

\n

XLR-11<\/p>\n<\/td>\n

\n

(1-(5-Fluoro-pentyl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone<\/p>\n<\/td>\n

\n

1364933-54-9<\/p>\n<\/td>\n<\/tr>\n

\n

392<\/p>\n<\/td>\n

\n

XLR-11 N-
(2-fluoropentyl)<\/p>\n<\/td>\n

\n

(1-(2-fluoropentyl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

393<\/p>\n<\/td>\n

\n

XLR-11 N-
(3-fluoropentyl)<\/p>\n<\/td>\n

\n

(1-(3-fluoropentyl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

394<\/p>\n<\/td>\n

\n

XLR-11 N-
(4-fluoropentyl)<\/p>\n<\/td>\n

\n

(1-(4-fluoropentyl)-1H<\/i>-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

395<\/p>\n<\/td>\n

\n

XLR-12<\/p>\n<\/td>\n

\n

(2,2,3,3 -tetramethylcyclopropyl)(1-(4,4,4-trifluorobutyl)-1H<\/i>-indol-3- yl)methanone<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

396<\/p>\n<\/td>\n

\n

Zipeprol<\/p>\n<\/td>\n

\n

\u03b1<\/i> \u2013 (\u03b1<\/i> \u2013 methoxybenzyl) \u2013 4 \u2013 (\u03b2<\/i> \u2013 methoxyphenethyl) \u2013 1- piperazineethanol<\/p>\n<\/td>\n

\n

34758-83-3<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

IID. C\u00e1c ch\u1ea5t sau<\/p>\n\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin CAS<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

397<\/p>\n<\/td>\n

\n

L\u00e1 Coca<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

398<\/p>\n<\/td>\n

\n

Thu\u1ed1c phi\u1ec7n v\u00e0 c\u00e1c ch\u1ebf ph\u1ea9m t\u1eeb thu\u1ed1c phi\u1ec7n<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00a0<\/p>\n

<\/a>DANH M\u1ee4C III<\/span><\/b><\/p>\n

<\/a>C\u00c1C CH\u1ea4T MA T\u00daY \u0110\u01af\u1ee2C D\u00d9NG TRONG PH\u00c2N T\u00cdCH, KI\u1ec2M NGHI\u1ec6M, NGHI\u00caN C\u1ee8U KHOA H\u1eccC, \u0110I\u1ec0U TRA T\u1ed8I PH\u1ea0M HO\u1eb6C TRONG L\u0128NH V\u1ef0C Y T\u1ebe, TH\u00da Y THEO QUY \u0110\u1ecaNH C\u1ee6A C\u01a0 QUAN C\u00d3 TH\u1ea8M QUY\u1ec0N
(Ban h\u00e0nh k\u00e8m theo Ngh\u1ecb \u0111\u1ecbnh s\u1ed1 73\/2018\/N\u0110-CP ng\u00e0y 15 th\u00e1ng 5 n\u0103m 2018 c\u1ee7a Ch\u00ednh ph\u1ee7)<\/i><\/p>\n

Danh M\u1ee5c n\u00e0y bao g\u1ed3m c\u1ea3 c\u00e1c mu\u1ed1i c\u00f3 th\u1ec3 t\u1ed3n t\u1ea1i c\u1ee7a c\u00e1c ch\u1ea5t d\u01b0\u1edbi \u0111\u00e2y:<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin CAS<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

1<\/p>\n<\/td>\n

\n

Allobarbital<\/p>\n<\/td>\n

\n

5,5 \u2013 diallylbarbituric acid<\/p>\n<\/td>\n

\n

52-43-7<\/p>\n<\/td>\n<\/tr>\n

\n

2<\/p>\n<\/td>\n

\n

Alprazolam<\/p>\n<\/td>\n

\n

8 \u2013 chloro -1 \u2013 methyl \u2013 6 \u2013 phenyl \u2013 4H \u2013 s<\/i> \u2013 triazolo [4,3 \u2013 a]<\/i> [1,4] \u2013 benzodiazepine<\/p>\n<\/td>\n

\n

289981-97-7<\/p>\n<\/td>\n<\/tr>\n

\n

3<\/p>\n<\/td>\n

\n

Aminorex<\/p>\n<\/td>\n

\n

2 \u2013 amino \u2013 5 \u2013 phenyl \u2013 2 \u2013 oxazoline<\/p>\n<\/td>\n

\n

2207-50-3<\/p>\n<\/td>\n<\/tr>\n

\n

4<\/p>\n<\/td>\n

\n

Amobarbital<\/p>\n<\/td>\n

\n

5 \u2013 ethyl \u2013 5 \u2013 isopentylbarbituric acid<\/p>\n<\/td>\n

\n

57-43-2<\/p>\n<\/td>\n<\/tr>\n

\n

5<\/p>\n<\/td>\n

\n

Barbital<\/p>\n<\/td>\n

\n

5,5 \u2013 diethylbarbituric acid<\/p>\n<\/td>\n

\n

57-44-3<\/p>\n<\/td>\n<\/tr>\n

\n

6<\/p>\n<\/td>\n

\n

Benzfetamine<\/p>\n<\/td>\n

\n

N<\/i> \u2013 benzyl \u2013 N \u2013 \u03b1 \u2013 <\/i>dimethylphenethylamine<\/p>\n<\/td>\n

\n

156-08-1<\/p>\n<\/td>\n<\/tr>\n

\n

7<\/p>\n<\/td>\n

\n

Bromazepam<\/p>\n<\/td>\n

\n

7 \u2013 bromo -1,3 \u2013 dihydro \u2013 5 \u2013 (2 \u2013 pyridyl) \u2013 2H \u2013 <\/i>1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

1812-30-2<\/p>\n<\/td>\n<\/tr>\n

\n

8<\/p>\n<\/td>\n

\n

Buprenorphine<\/p>\n<\/td>\n

\n

21 \u2013 cyclopropyl \u2013 <\/i>7 \u2013 \u03b1-<\/i> [(S<\/i>) \u2013 1 \u2013 hydroxy \u2013 1,2,2 \u2013 trimethylpropyl] \u2013 6,14 \u2013 endo<\/i> \u2013 ethano \u2013 6,7,8,14 \u2013 tetrahydrooripavine<\/p>\n<\/td>\n

\n

52485-79-7<\/p>\n<\/td>\n<\/tr>\n

\n

9<\/p>\n<\/td>\n

\n

Butalbital<\/p>\n<\/td>\n

\n

5 \u2013 allyl \u2013 5 \u2013 isobutylbarbituric acid<\/p>\n<\/td>\n

\n

77-26-9<\/p>\n<\/td>\n<\/tr>\n

\n

10<\/p>\n<\/td>\n

\n

Butobarbital<\/p>\n<\/td>\n

\n

5 \u2013 butyl \u2013 5 \u2013 ethylbarbituric acid<\/p>\n<\/td>\n

\n

77-28-1<\/p>\n<\/td>\n<\/tr>\n

\n

11<\/p>\n<\/td>\n

\n

Camazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 1,3 \u2013 dihydro \u2013 3 \u2013 hydroxy \u2013 1 \u2013 methyl \u2013 5 \u2013 phenyl \u2013 2H <\/i>\u2013 1,4 benzodiazepin \u2013 2 \u2013 one dimethylcarbamate (ester)<\/p>\n<\/td>\n

\n

36104-80-0<\/p>\n<\/td>\n<\/tr>\n

\n

12<\/p>\n<\/td>\n

\n

Cathine ((+)norpseudoephedrine )<\/p>\n<\/td>\n

\n

(+) \u2013 (R)- <\/i>\u03b1 \u2013<\/i> [(R<\/i>) \u2013 1 \u2013 aminoethyl] benzylalcohol<\/p>\n<\/td>\n

\n

492-39-7<\/p>\n<\/td>\n<\/tr>\n

\n

13<\/p>\n<\/td>\n

\n

Chlordiazepoxide<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 2 \u2013 (methylamino) \u2013 5 \u2013 phenyl \u2013 3H \u2013 <\/i>1,4 \u2013 benzodiazepine \u2013 4 \u2013 oxide<\/p>\n<\/td>\n

\n

58-25-3<\/p>\n<\/td>\n<\/tr>\n

\n

14<\/p>\n<\/td>\n

\n

Clobazam<\/p>\n<\/td>\n

\n

7 \u2013 chloro -1 \u2013 methyl \u2013 5 \u2013 phenyl \u2013 1H <\/i>\u2013 1,5 \u2013 benzodiazepine \u2013 2,4 (3H, 5H)<\/i> \u2013 dione<\/p>\n<\/td>\n

\n

22316-47-8<\/p>\n<\/td>\n<\/tr>\n

\n

15<\/p>\n<\/td>\n

\n

Clonazepam<\/p>\n<\/td>\n

\n

5 \u2013 (o<\/i>\u2013 chlorophenyl) \u2013 1,3 \u2013 nitro \u2013 2H <\/i>\u2013 1,4 \u2013 benzodiazepine \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

1622-61-3<\/p>\n<\/td>\n<\/tr>\n

\n

16<\/p>\n<\/td>\n

\n

Clorazepate<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 2,3 \u2013 dihydro \u2013 2 \u2013 oxo \u2013 5 \u2013 phenyl \u2013 1H <\/i>\u2013 1,4 \u2013 benzodiazepine \u2013 3 \u2013 carboxylic acid<\/p>\n<\/td>\n

\n

23887-31-2<\/p>\n<\/td>\n<\/tr>\n

\n

17<\/p>\n<\/td>\n

\n

Clotiazepam<\/p>\n<\/td>\n

\n

5 \u2013 (2 \u2013 chlorophenyl) \u2013 7 \u2013 ethyl \u2013 1,3 \u2013 dihydro \u2013 1 \u2013 methyl \u2013 2H \u2013 thieno [2,3,e] \u2013 1 \u2013 4 \u2013 diazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

33671-46-4<\/p>\n<\/td>\n<\/tr>\n

\n

18<\/p>\n<\/td>\n

\n

Cloxazolam<\/p>\n<\/td>\n

\n

10 \u2013 chloro \u2013 11b \u2013 <\/i>(o \u2013<\/i> chlorophenyl) \u2013 2,3,7,11b<\/i> \u2013 tetrahydrooxazolon \u2013 [3,2-d<\/i>]<\/i>[1,4] benzodiazepin \u2013 6(5H<\/i>) \u2013 one<\/p>\n<\/td>\n

\n

24166-13-0<\/p>\n<\/td>\n<\/tr>\n

\n

19<\/p>\n<\/td>\n

\n

Cyclobarbital<\/p>\n<\/td>\n

\n

5 \u2013 (1 \u2013 cyclohexen \u2013 1 \u2013 yl) \u2013 5 \u2013 ethylbarbituric acid<\/p>\n<\/td>\n

\n

52-31-3<\/p>\n<\/td>\n<\/tr>\n

\n

20<\/p>\n<\/td>\n

\n

Delorazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 5 \u2013 (o<\/i>-chlorophenyl) -1,3 \u2013 dihydro \u2013 2H \u2013<\/i> 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

2894-67-9<\/p>\n<\/td>\n<\/tr>\n

\n

21<\/p>\n<\/td>\n

\n

Diazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 1,3 \u2013 dihydro \u2013 1 \u2013 methyl \u2013 5 \u2013 phenyl \u2013 2H <\/i>\u2013 1,4 \u2013 benzodiazepin -2 \u2013 one<\/p>\n<\/td>\n

\n

439-14-5<\/p>\n<\/td>\n<\/tr>\n

\n

22<\/p>\n<\/td>\n

\n

Estazolam<\/p>\n<\/td>\n

\n

8-chloro \u2013 6 \u2013 phenyl \u2013 4H \u2013 s<\/i> \u2013 triazolo \u2013 [4,3 \u2013 a<\/i>] [1,4 \u2013 benzodiazepin<\/p>\n<\/td>\n

\n

29975-16-4<\/p>\n<\/td>\n<\/tr>\n

\n

23<\/p>\n<\/td>\n

\n

Ethchlorvynol<\/p>\n<\/td>\n

\n

1 \u2013 choloro-3 \u2013 ethyl \u2013 1 \u2013 penten \u2013 4yn \u2013 3 \u2013 ol<\/p>\n<\/td>\n

\n

113-18-8<\/p>\n<\/td>\n<\/tr>\n

\n

24<\/p>\n<\/td>\n

\n

Ethinamate<\/p>\n<\/td>\n

\n

1 \u2013 ethynylcyclohexanolcarbamate<\/p>\n<\/td>\n

\n

126-52-3<\/p>\n<\/td>\n<\/tr>\n

\n

25<\/p>\n<\/td>\n

\n

Ethylloflazepate<\/p>\n<\/td>\n

\n

Ethyl \u2013 7 \u2013 chloro \u2013 5 \u2013 (o<\/i> \u2013 fluorophenyl) \u2013 2 \u2013 3 \u2013 dihydro \u2013 2 \u2013 oxo \u2013 1H <\/i>\u2013 1,4 \u2013 benzodiazepin \u2013 3 \u2013\u00a0 carboxylate<\/p>\n<\/td>\n

\n

29177-84-2<\/p>\n<\/td>\n<\/tr>\n

\n

26<\/p>\n<\/td>\n

\n

Etilamfetamine<\/p>\n<\/td>\n

\n

N<\/i>-ethyl \u2013 \u03b1<\/i> \u2013 methylphenylethylamine<\/p>\n<\/td>\n

\n

457-87-4<\/p>\n<\/td>\n<\/tr>\n

\n

27<\/p>\n<\/td>\n

\n

Fencamfamine<\/p>\n<\/td>\n

\n

N<\/i>-ethyl \u2013 3 \u2013 phenyl \u2013 2 \u2013 norbomanamine<\/p>\n<\/td>\n

\n

1209-98-9<\/p>\n<\/td>\n<\/tr>\n

\n

28<\/p>\n<\/td>\n

\n

Fenproporex<\/p>\n<\/td>\n

\n

(\u00b1) \u2013 3 \u2013 [(\u03b1 \u2013 methylphenylethyl) aminol propionitrile<\/p>\n<\/td>\n

\n

16397-28-7<\/p>\n<\/td>\n<\/tr>\n

\n

29<\/p>\n<\/td>\n

\n

Fludiazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 5 \u2013 (o<\/i> \u2013 fluorofenyl) -1,3 \u2013 dihydro \u2013 2H <\/i>\u2013 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

3900-31-0<\/p>\n<\/td>\n<\/tr>\n

\n

30<\/p>\n<\/td>\n

\n

Flunitrazepam<\/p>\n<\/td>\n

\n

5 \u2013 (o<\/i> \u2013 fluorophenyl) \u2013 1,3 \u2013 dihydro -1 \u2013 methyl \u2013 7 \u2013 nitro \u2013 2H<\/i> \u2013 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

1622-62-4<\/p>\n<\/td>\n<\/tr>\n

\n

31<\/p>\n<\/td>\n

\n

Flurazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro -1 \u2013 [2 \u2013 (diethylamino) ethyl] \u2013 5 \u2013 (o<\/i>-fluorophenyl) \u2013 1,3 \u2013 dihydro \u2013 2H \u2013 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

17617-23-1<\/p>\n<\/td>\n<\/tr>\n

\n

32<\/p>\n<\/td>\n

\n

Glutethimide<\/p>\n<\/td>\n

\n

2 \u2013 ethyl \u2013 2 \u2013 phenylglutarimide<\/p>\n<\/td>\n

\n

77-21-4<\/p>\n<\/td>\n<\/tr>\n

\n

33<\/p>\n<\/td>\n

\n

Halazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 1,3 \u2013 dihydro \u2013 5 \u2013 phenyl \u2013 1 \u2013 (2,2,2 \u2013 trifluoroethyl) \u2013 2H<\/i> \u2013 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

23092-17-3<\/p>\n<\/td>\n<\/tr>\n

\n

34<\/p>\n<\/td>\n

\n

Haloxazolam<\/p>\n<\/td>\n

\n

10 \u2013 bromo \u2013 11b \u2013 <\/i>(o \u2013<\/i> fluorophenyl) \u2013 2,3,7,11b<\/i> \u2013 tetrahydrooxazolo [3,2 \u2013 d<\/i>] [1,4] benzodiazepin \u2013 6 \u2013 (5H) \u2013 one<\/p>\n<\/td>\n

\n

59128-97-1<\/p>\n<\/td>\n<\/tr>\n

\n

35<\/p>\n<\/td>\n

\n

Ketamine<\/p>\n<\/td>\n

\n

(\u00b1)-2-(2-Chlorophenyl)-2- methylaminocyclohexanone<\/p>\n<\/td>\n

\n

6740-88-1<\/p>\n<\/td>\n<\/tr>\n

\n

36<\/p>\n<\/td>\n

\n

Ketazolam<\/p>\n<\/td>\n

\n

11 \u2013 chloro \u2013 8 \u2013 12b<\/i> \u2013 dihydro \u2013 2,8 \u2013 dimethyl -12b<\/i> \u2013 phenyl \u2013 4H \u2013<\/i> [1,3] \u2013 oxazino [3,2 \u2013 d]<\/i> [1,4] benzodiazepin \u2013 4,7 (6H)<\/i> \u2013 dione<\/p>\n<\/td>\n

\n

27223-35-4<\/p>\n<\/td>\n<\/tr>\n

\n

37<\/p>\n<\/td>\n

\n

Lefetamine (SPA)<\/p>\n<\/td>\n

\n

(-) \u2013 N,N<\/i> \u2013 dimethyl \u2013 1,2 \u2013 diphenylethylamine<\/p>\n<\/td>\n

\n

7262-75-1<\/p>\n<\/td>\n<\/tr>\n

\n

38<\/p>\n<\/td>\n

\n

Loprazolam<\/p>\n<\/td>\n

\n

6 \u2013 (o \u2013 chlorophenyl) \u2013 2,4 \u2013 dihydro \u2013 2 \u2013 [(4-methyl \u2013 1 \u2013 [piperazinyl) methylene] \u2013 8 \u2013 nitro -1 \u2013 H \u2013<\/i> imidazo \u2013 [1,2 \u2013 a<\/i>] [1,4] benzodiazepin \u2013 1 \u2013 one<\/p>\n<\/td>\n

\n

61197-73-7<\/p>\n<\/td>\n<\/tr>\n

\n

39<\/p>\n<\/td>\n

\n

Lorazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 5 \u2013 (o<\/i> \u2013 chlorofenyl) \u2013 1,3 \u2013 dihydro \u2013 3 \u2013 hydroxy \u2013 2H \u2013 <\/i>1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

846-49-1<\/p>\n<\/td>\n<\/tr>\n

\n

40<\/p>\n<\/td>\n

\n

Lormetazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 5 \u2013 (o<\/i> \u2013 chlorofenyl) -1,3 \u2013 dihydro \u2013 3 \u2013 hydroxy \u2013 1 \u2013 methyl \u2013 2H <\/i>\u2013 1,4 \u2013 benzodiazepin \u2013 2 \u2013 \u00a0one<\/p>\n<\/td>\n

\n

848-75-9<\/p>\n<\/td>\n<\/tr>\n

\n

41<\/p>\n<\/td>\n

\n

Mazindol<\/p>\n<\/td>\n

\n

5 \u2013 (p<\/i>-chlorophenyl) \u2013 2,5 dihydro \u2013 3H \u2013 <\/i>imidazo \u2013 (2,1 \u2013 a)<\/i> isoindol \u2013 5 \u2013 ol<\/p>\n<\/td>\n

\n

22232-71-9<\/p>\n<\/td>\n<\/tr>\n

\n

42<\/p>\n<\/td>\n

\n

Medazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 2,3 \u2013 dihydro \u2013 1 \u2013 methyl \u2013 5 \u2013 phenyl \u2013 1H \u2013 <\/i>1,4 \u2013 benzodiazepine<\/p>\n<\/td>\n

\n

2898-12-6<\/p>\n<\/td>\n<\/tr>\n

\n

43<\/p>\n<\/td>\n

\n

Mefenorex<\/p>\n<\/td>\n

\n

N-(<\/i>3 \u2013 chloropropyl) \u2013 \u03b1<\/i> \u2013 methylphenethylamine<\/p>\n<\/td>\n

\n

17243-57-1<\/p>\n<\/td>\n<\/tr>\n

\n

44<\/p>\n<\/td>\n

\n

Meprobamate<\/p>\n<\/td>\n

\n

2 \u2013 methyl \u2013 2 \u2013 propyl -1,3 \u2013 propanediol dicarbamate<\/p>\n<\/td>\n

\n

57-53-4<\/p>\n<\/td>\n<\/tr>\n

\n

45<\/p>\n<\/td>\n

\n

Mesocarb<\/p>\n<\/td>\n

\n

3 \u2013 (\u03b1<\/i> \u2013 methylphenethyl) \u2013 N<\/i> \u2013 (phenylcarbamoyl) syndnoneimine<\/p>\n<\/td>\n

\n

34262-84-5<\/p>\n<\/td>\n<\/tr>\n

\n

46<\/p>\n<\/td>\n

\n

Methylphenobarbital<\/p>\n<\/td>\n

\n

5 \u2013 ethyl \u2013 1 \u2013 methyl \u2013 5 \u2013 phenylbarbituric acid<\/p>\n<\/td>\n

\n

115-38-8<\/p>\n<\/td>\n<\/tr>\n

\n

47<\/p>\n<\/td>\n

\n

Methyprylon<\/p>\n<\/td>\n

\n

3,3 \u2013 diethyl \u2013 5 \u2013 methyl \u2013 2,4 \u2013 piperidine \u2013 dione<\/p>\n<\/td>\n

\n

125-64-4<\/p>\n<\/td>\n<\/tr>\n

\n

48<\/p>\n<\/td>\n

\n

Midazolam<\/p>\n<\/td>\n

\n

8 \u2013 chloro \u2013 6 \u2013 (o<\/i> \u2013 fluorophenyl) \u2013 1 \u2013 methyl \u2013 4H \u2013<\/i> imidazo \u2013 [1,5 \u2013 a<\/i>] [1,4] \u2013 benzodiazepin<\/p>\n<\/td>\n

\n

59467-70-8<\/p>\n<\/td>\n<\/tr>\n

\n

49<\/p>\n<\/td>\n

\n

Nimetazepam<\/p>\n<\/td>\n

\n

1,3 \u2013 dihydro -1 \u2013 methyl \u2013 7 \u2013 nitro \u2013 5 \u2013 phenyl \u2013 2H \u2013 <\/i>1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

2011-67-8<\/p>\n<\/td>\n<\/tr>\n

\n

50<\/p>\n<\/td>\n

\n

Nitrazepam<\/p>\n<\/td>\n

\n

1,3 \u2013 dihydro \u2013 7 \u2013 nitro \u2013 5 phenyl \u2013 2H <\/i>\u2013 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

146-22-5<\/p>\n<\/td>\n<\/tr>\n

\n

51<\/p>\n<\/td>\n

\n

Nordazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 1,3 \u2013 dihydro \u2013 5 \u2013 phenyl \u2013 2H \u2013<\/i> 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

1088-11-5<\/p>\n<\/td>\n<\/tr>\n

\n

52<\/p>\n<\/td>\n

\n

Oxazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 1,3 \u2013 dihydro \u2013 3 \u2013 hydroxy \u2013 5 \u2013 phenyl \u2013 2H<\/i> \u2013 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

604-75-1<\/p>\n<\/td>\n<\/tr>\n

\n

53<\/p>\n<\/td>\n

\n

Oxazolam<\/p>\n<\/td>\n

\n

10 \u2013 chloro \u2013 2,3,7,11b<\/i> \u2013 tetrahydro \u2013 2 \u2013 methyl \u2013 11b \u2013<\/i> phenyloxazolo [3,2 \u2013 d<\/i>]<\/i>[1,4] benzodiazepin \u2013 6(5H)<\/i> \u2013 one<\/p>\n<\/td>\n

\n

24143-17-7<\/p>\n<\/td>\n<\/tr>\n

\n

54<\/p>\n<\/td>\n

\n

Pemoline<\/p>\n<\/td>\n

\n

2 \u2013 amino \u2013 5 \u2013 phenyl \u2013 2 \u2013 oxazolin \u2013 4 \u2013 one<\/p>\n<\/td>\n

\n

2152-34-3<\/p>\n<\/td>\n<\/tr>\n

\n

55<\/p>\n<\/td>\n

\n

Pentazocine<\/p>\n<\/td>\n

\n

(2R*,6R*, 11R*) \u2013 1,2,3,4,5,6 \u2013 hexahydro \u2013 6,11 \u2013 dimethyl \u2013 3 \u2013 (3 \u2013 methyl \u2013 2 \u2013 butenyl) \u2013 2,6 \u2013 methano \u2013 3 \u2013 benzazocin \u2013 8 \u2013 ol<\/p>\n<\/td>\n

\n

55643-30-6<\/p>\n<\/td>\n<\/tr>\n

\n

56<\/p>\n<\/td>\n

\n

Pentobarbital<\/p>\n<\/td>\n

\n

5 \u2013 ethyl \u2013 5 \u2013 (1 \u2013 methylbutyl) barbituric acid<\/p>\n<\/td>\n

\n

76-74-4<\/p>\n<\/td>\n<\/tr>\n

\n

57<\/p>\n<\/td>\n

\n

Phendimetrazine<\/p>\n<\/td>\n

\n

(+) \u2013 3,4 \u2013 dimethyl \u2013 2 \u2013 phenylmorpholine<\/p>\n<\/td>\n

\n

634-03-7<\/p>\n<\/td>\n<\/tr>\n

\n

58<\/p>\n<\/td>\n

\n

Phenobarbital<\/p>\n<\/td>\n

\n

5 \u2013 ethyl \u2013 5 \u2013 phenylbarbituric acid<\/p>\n<\/td>\n

\n

50-06-6<\/p>\n<\/td>\n<\/tr>\n

\n

59<\/p>\n<\/td>\n

\n

Phentermine<\/p>\n<\/td>\n

\n

\u03b1, \u03b1<\/i> \u2013 dimethylphenethylamine<\/p>\n<\/td>\n

\n

122-09-8<\/p>\n<\/td>\n<\/tr>\n

\n

60<\/p>\n<\/td>\n

\n

Pinazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 1,3 \u2013 dihydro \u2013 5 \u2013 phenyl \u2013 1 \u2013 (2 \u2013 propynyl) \u2013 2H <\/i>\u2013 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

52463-83-9<\/p>\n<\/td>\n<\/tr>\n

\n

61<\/p>\n<\/td>\n

\n

Pipradrol<\/p>\n<\/td>\n

\n

1 \u2013 1 \u2013 diphenyl \u2013 1 \u2013 (2 \u2013 piperidyl) \u2013 methanol<\/p>\n<\/td>\n

\n

467-60-7<\/p>\n<\/td>\n<\/tr>\n

\n

62<\/p>\n<\/td>\n

\n

Prazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 1 \u2013 (cyclopropylmethyl) \u2013 1,3 \u2013 dihydro \u2013 5 \u2013 phenyl \u2013 2H<\/i> \u2013 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

2955-38-6<\/p>\n<\/td>\n<\/tr>\n

\n

63<\/p>\n<\/td>\n

\n

Pyrovalerone<\/p>\n<\/td>\n

\n

4\u2019 \u2013 methyl \u2013 2 \u2013 (1 \u2013 pyrrolidinyl) valerophenone<\/p>\n<\/td>\n

\n

3563-49-3<\/p>\n<\/td>\n<\/tr>\n

\n

64<\/p>\n<\/td>\n

\n

Secbutabarbital<\/p>\n<\/td>\n

\n

5 \u2013 sec<\/i> \u2013 butyl \u2013 5 \u2013 ethylbarbituric acid<\/p>\n<\/td>\n

\n

125-40-6<\/p>\n<\/td>\n<\/tr>\n

\n

65<\/p>\n<\/td>\n

\n

Temazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro -1,3 \u2013 dihydro \u2013 3 \u2013 hydroxy -1 \u2013 methyl \u2013 5 \u2013 phenyl \u2013 2H \u2013<\/i> 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

846-50-4<\/p>\n<\/td>\n<\/tr>\n

\n

66<\/p>\n<\/td>\n

\n

Tetrazepam<\/p>\n<\/td>\n

\n

7 \u2013 chloro \u2013 5 \u2013 (1 \u2013 cyclohexen \u2013 1 \u2013 yl) \u2013 1,3 \u2013 dihydro \u2013 1 methyl \u2013 2H<\/i> \u2013 1,4 \u2013 benzodiazepin \u2013 2 \u2013 one<\/p>\n<\/td>\n

\n

10379-14-3<\/p>\n<\/td>\n<\/tr>\n

\n

67<\/p>\n<\/td>\n

\n

Tiletamine<\/p>\n<\/td>\n

\n

2 \u2013 (ethylamino) \u2013 2 \u2013 thiophen \u2013 2 -yl cyclohexan \u2013 1 \u00a0\u2013 one<\/p>\n<\/td>\n

\n

14176-49-9<\/p>\n<\/td>\n<\/tr>\n

\n

68<\/p>\n<\/td>\n

\n

Triazolam<\/p>\n<\/td>\n

\n

8 \u2013 chloro \u2013 6 \u2013 (o<\/i> \u2013 chlorophenyl) \u2013 1 \u2013 methyl \u2013 4H <\/i>\u2013 s \u2013<\/i> triazolo [4,3 \u2013 a<\/i>] [1,4] benzodiazepine<\/p>\n<\/td>\n

\n

28911-01-5<\/p>\n<\/td>\n<\/tr>\n

\n

69<\/p>\n<\/td>\n

\n

Vinylbital<\/p>\n<\/td>\n

\n

5 \u2013 (1 \u2013 methylbutyl) \u2013 5 \u2013 vinylbarbituric acid<\/p>\n<\/td>\n

\n

2430-49-1<\/p>\n<\/td>\n<\/tr>\n

\n

70<\/p>\n<\/td>\n

\n

Zolazepam<\/p>\n<\/td>\n

\n

4 \u2013 (2 \u2013 fluorophenyl) \u2013 1,3,8 \u2013 trimethyl -6H<\/i> \u2013 pyrazolo [3,4-e] [1,4] diazepin \u2013 7 -one<\/p>\n<\/td>\n

\n

31352-82-6<\/p>\n<\/td>\n<\/tr>\n

\n

71<\/p>\n<\/td>\n

\n

Zolpidem<\/p>\n<\/td>\n

\n

N, N,<\/i> 6 \u2013 trimethyl \u2013 2 \u2013 p<\/i> \u2013 tolylimidazol [1,2 \u2013 a]<\/i> pyridine \u2013 3 \u2013 acetamide<\/p>\n<\/td>\n

\n

82626-48-0<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/a>DANH M\u1ee4C IV<\/span><\/b><\/p>\n

<\/a>\u201cC\u00c1C TI\u1ec0N CH\u1ea4T\u201d
(Ban h\u00e0nh k\u00e8m theo Ngh\u1ecb \u0111\u1ecbnh s\u1ed1 73\/2018\/N\u0110-CP ng\u00e0y 15 th\u00e1ng 5 n\u0103m 2018 c\u1ee7a Ch\u00ednh ph\u1ee7)<\/i><\/p>\n

IVA: C\u00e1c ti\u1ec1n ch\u1ea5t thi\u1ebft y\u1ebfu, tham gia v\u00e0o c\u1ea5u tr\u00fac ch\u1ea5t ma t\u00fay.<\/p>\n

Danh M\u1ee5c n\u00e0y bao g\u1ed3m c\u1ea3 c\u00e1c mu\u1ed1i c\u00f3 th\u1ec3 t\u1ed3n t\u1ea1i c\u1ee7a c\u00e1c ch\u1ea5t c\u00f3 ghi ch\u00fa *.<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin CAS<\/b><\/p>\n<\/td>\n

\n

M\u00e3 h\u00e0ng h\u00f3a HS<\/b><\/p>\n<\/td>\n

\n

C\u01a1 quan qu\u1ea3n l\u00fd<\/b><\/p>\n<\/td>\n

\n

Ghi ch\u00fa<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

1<\/p>\n<\/td>\n

\n

1-phenyl-2-propanone (P2P)<\/p>\n<\/td>\n

\n

1-phenyl-2-propanone<\/p>\n<\/td>\n

\n

103-79-7<\/p>\n<\/td>\n

\n

2914.31.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

2<\/p>\n<\/td>\n

\n

Acetic anhydride<\/p>\n<\/td>\n

\n

Acetic oxide<\/p>\n<\/td>\n

\n

108-24-7<\/p>\n<\/td>\n

\n

2915.24.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

3<\/p>\n<\/td>\n

\n

Alpha<\/i>-phenyl acetoacetonitrile (APAAN)<\/p>\n<\/td>\n

\n

3-oxo-2-phenylbutanenitrile<\/p>\n<\/td>\n

\n

4468-48-8<\/p>\n<\/td>\n

\n

2926.90.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

4<\/p>\n<\/td>\n

\n

Anthranilic acid<\/p>\n<\/td>\n

\n

2 \u2013 Aminobenzoic acid<\/p>\n<\/td>\n

\n

118-92-3<\/p>\n<\/td>\n

\n

2922.43.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n

\n

*<\/p>\n<\/td>\n<\/tr>\n

\n

5<\/p>\n<\/td>\n

\n

Benzaldehyde<\/p>\n<\/td>\n

\n

Benzaldehyde<\/p>\n<\/td>\n

\n

100-52-7<\/p>\n<\/td>\n

\n

2912.21.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

6<\/p>\n<\/td>\n

\n

Benzyl cyanide<\/p>\n<\/td>\n

\n

2-Phenylacetonenitrile<\/p>\n<\/td>\n

\n

140-29-4<\/p>\n<\/td>\n

\n

2926.90.95<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

7<\/p>\n<\/td>\n

\n

Gamma<\/i>-butyro lactone (GBL)<\/p>\n<\/td>\n

\n

Dihidrofuran-2(3H<\/i>)-one<\/p>\n<\/td>\n

\n

96-48-0<\/p>\n<\/td>\n

\n

2932.29.80<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

8<\/p>\n<\/td>\n

\n

Isosafrole<\/p>\n<\/td>\n

\n

1,3 \u2013 Benzodioxole \u2013 5 \u2013 (1 \u2013 propenyl)<\/p>\n<\/td>\n

\n

120-58-1<\/p>\n<\/td>\n

\n

2932.91.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

9<\/p>\n<\/td>\n

\n

Lysergic acid<\/p>\n<\/td>\n

\n

(8b) \u2013 9,10 \u2013 didehydro \u2013 6 \u2013 methylergolin \u2013 8 \u2013 carboxylic acid<\/p>\n<\/td>\n

\n

82-58-6<\/p>\n<\/td>\n

\n

2939.63.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n

\n

*<\/p>\n<\/td>\n<\/tr>\n

\n

10<\/p>\n<\/td>\n

\n

N-acetylanthranilic acid<\/p>\n<\/td>\n

\n

1 \u2013 Acetylamino \u2013 2 \u2013 carboxybenzene<\/p>\n<\/td>\n

\n

89-52-1<\/p>\n<\/td>\n

\n

2924.23.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n

\n

*<\/p>\n<\/td>\n<\/tr>\n

\n

11<\/p>\n<\/td>\n

\n

Phenylacetic acid<\/p>\n<\/td>\n

\n

Benzeneacetic acid<\/p>\n<\/td>\n

\n

103-82-2<\/p>\n<\/td>\n

\n

2916.34.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n

\n

*<\/p>\n<\/td>\n<\/tr>\n

\n

12<\/p>\n<\/td>\n

\n

Piperidine<\/p>\n<\/td>\n

\n

Cyclopentimine<\/p>\n<\/td>\n

\n

110-89-4<\/p>\n<\/td>\n

\n

2933.32.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n

\n

*<\/p>\n<\/td>\n<\/tr>\n

\n

13<\/p>\n<\/td>\n

\n

Piperonal<\/p>\n<\/td>\n

\n

1,3-Benzodioxole-5-carbaldehyde<\/p>\n<\/td>\n

\n

120-57-0<\/p>\n<\/td>\n

\n

2932.93.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n

\n

*<\/p>\n<\/td>\n<\/tr>\n

\n

14<\/p>\n<\/td>\n

\n

Piperonyl methyl ketone<\/p>\n<\/td>\n

\n

3,4 \u2013 methylenedioxyphenyl \u2013 2 \u2013 propanone<\/p>\n<\/td>\n

\n

4676-39-5<\/p>\n<\/td>\n

\n

2932.92.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng \u00a0<\/b>Th\u01b0\u01a1ng<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

15<\/p>\n<\/td>\n

\n

Safrole<\/p>\n<\/td>\n

\n

5-(prop-2-en-1-yl)-2H<\/i>-1,3-benzodioxole<\/p>\n<\/td>\n

\n

94-59-7<\/p>\n<\/td>\n

\n

2932.94.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

16<\/p>\n<\/td>\n

\n

Ephedrine<\/p>\n<\/td>\n

\n

(1R<\/i>,2R<\/i>)-2-methylamino-1 \u2013 phenyl propan \u2013 1 \u2013 ol<\/p>\n<\/td>\n

\n

299-42-3<\/p>\n<\/td>\n

\n

2939.41.00<\/p>\n<\/td>\n

\n

B\u1ed9 Yt\u1ebf<\/p>\n<\/td>\n

\n

*<\/p>\n<\/td>\n<\/tr>\n

\n

17<\/p>\n<\/td>\n

\n

Ergometrine<\/p>\n<\/td>\n

\n

N<\/i> \u2013 (2 \u2013 hydroxy \u2013 1 \u2013 methylethyl) \u2013 D (+) \u2013 lysergamide<\/p>\n<\/td>\n

\n

60-79-7<\/p>\n<\/td>\n

\n

2939.61.00<\/p>\n<\/td>\n

\n

B\u1ed9 Y t\u1ebf<\/p>\n<\/td>\n

\n

*<\/p>\n<\/td>\n<\/tr>\n

\n

18<\/p>\n<\/td>\n

\n

Ergotamine<\/p>\n<\/td>\n

\n

Ergotaman \u2013 3\u2019, 6\u2019, 18 \u2013 trione , 12\u2019- hydroxy \u2013 2\u2019 -methyl \u2013 5\u2019 \u2013 (phenylmethyl) \u2013 (5\u2019a<\/i>)<\/p>\n<\/td>\n

\n

113-15-5<\/p>\n<\/td>\n

\n

2939.62.00<\/p>\n<\/td>\n

\n

B\u1ed9 Y t\u1ebf<\/p>\n<\/td>\n

\n

*<\/p>\n<\/td>\n<\/tr>\n

\n

19<\/p>\n<\/td>\n

\n

N-Ethylephedrine<\/p>\n<\/td>\n

\n

1-Ethylephedrine<\/p>\n<\/td>\n

\n

7681-79-0<\/p>\n<\/td>\n

\n

2939.42.00<\/p>\n<\/td>\n

\n

B\u1ed9 Y t\u1ebf<\/p>\n<\/td>\n

\n

*<\/p>\n<\/td>\n<\/tr>\n

\n

20<\/p>\n<\/td>\n

\n

N-Ethylpseudo Ephedrine<\/p>\n<\/td>\n

\n

Ethyl methyl amino- phenyl-propane -1-ol<\/p>\n<\/td>\n

\n

258827- 65-5<\/p>\n<\/td>\n

\n

2939.49.90<\/p>\n<\/td>\n

\n

B\u1ed9 Y t\u1ebf<\/p>\n<\/td>\n

\n

*<\/p>\n<\/td>\n<\/tr>\n

\n

21<\/p>\n<\/td>\n

\n

N-Methylephedrine<\/p>\n<\/td>\n

\n

(1R,2S)-2-(Dimethylamino)-1-phenyl-1-propanol<\/p>\n<\/td>\n

\n

552-79-4<\/p>\n<\/td>\n

\n

2939.49.90<\/p>\n<\/td>\n

\n

B\u1ed9 Y t\u1ebf<\/p>\n<\/td>\n

\n

*<\/p>\n<\/td>\n<\/tr>\n

\n

22<\/p>\n<\/td>\n

\n

N-Methylpseudoe
phedrine<\/p>\n<\/td>\n

\n

\u00a0Dimethylamino-phenyl-propane-1-ol<\/p>\n<\/td>\n

\n

51018-28- 1<\/p>\n<\/td>\n

\n

2939.49.90<\/p>\n<\/td>\n

\n

B\u1ed9 Yt\u1ebf<\/p>\n<\/td>\n

\n

*<\/p>\n<\/td>\n<\/tr>\n

\n

23<\/p>\n<\/td>\n

\n

Norephedrine (Phenylpropano
lamine)<\/p>\n<\/td>\n

\n

\u03b1<\/i>-(1-Aminoethyl) enzylalcohol<\/p>\n<\/td>\n

\n

14838-15- 4<\/p>\n<\/td>\n

\n

2939.44.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng an<\/p>\n<\/td>\n

\n

*<\/p>\n<\/td>\n<\/tr>\n

\n

24<\/p>\n<\/td>\n

\n

Pseudoephedrine<\/p>\n<\/td>\n

\n

(1S, 2S) \u2013 2-methylamino \u2013 1 \u2013 phenyl propane -1 \u2013 ol<\/p>\n<\/td>\n

\n

90-82-4<\/p>\n<\/td>\n

\n

2939.42.00<\/p>\n<\/td>\n

\n

B\u1ed9 Y t\u1ebf<\/p>\n<\/td>\n

\n

*<\/p>\n<\/td>\n<\/tr>\n

\n

25<\/p>\n<\/td>\n

\n

N-<\/span><\/i>Phenethyl-4-piperidinone <\/span><\/p>\n

(NPP)<\/span><\/p>\n<\/td>\n

\n

1- (2-Phenylethyl) piperidine-4-one<\/p>\n<\/td>\n

\n

3972-64-0<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng an<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n<\/tr>\n

\n

26<\/p>\n<\/td>\n

\n

4-ANPP<\/span><\/p>\n<\/td>\n

\n

4-aminophenyl-1-phenethylpiperidine<\/p>\n<\/td>\n

\n

21409-26- 7<\/p>\n<\/td>\n

\n

\u00a0<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng an<\/p>\n<\/td>\n

\n

*<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

IVB: C\u00e1c ti\u1ec1n ch\u1ea5t l\u00e0 dung m\u00f4i, ch\u1ea5t x\u00fac t\u00e1c trong qu\u00e1 tr\u00ecnh s\u1ea3n xu\u1ea5t ch\u1ea5t ma t\u00fay.<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

STT<\/b><\/p>\n<\/td>\n

\n

T\u00ean ch\u1ea5t<\/b><\/p>\n<\/td>\n

\n

T\u00ean khoa h\u1ecdc<\/b><\/p>\n<\/td>\n

\n

M\u00e3 th\u00f4ng tin CAS<\/b><\/p>\n<\/td>\n

\n

M\u00e3 h\u00e0ng h\u00f3a HS<\/b><\/p>\n<\/td>\n

\n

C\u01a1 quan qu\u1ea3n l\u00fd<\/b><\/p>\n<\/td>\n<\/tr>\n

\n

27<\/p>\n<\/td>\n

\n

Acetic acid<\/p>\n<\/td>\n

\n

Ethanoic acid<\/p>\n<\/td>\n

\n

64-19-7<\/p>\n<\/td>\n

\n

2915.21.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n<\/tr>\n

\n

28<\/p>\n<\/td>\n

\n

Acetone<\/p>\n<\/td>\n

\n

2-propanone<\/p>\n<\/td>\n

\n

67-64-1<\/p>\n<\/td>\n

\n

2914.11.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n<\/tr>\n

\n

29<\/p>\n<\/td>\n

\n

Acetyl chloride<\/p>\n<\/td>\n

\n

Acetyl chloride<\/p>\n<\/td>\n

\n

75-36-5<\/p>\n<\/td>\n

\n

2915.90.70<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n<\/tr>\n

\n

30<\/p>\n<\/td>\n

\n

Ammonium formate<\/p>\n<\/td>\n

\n

Formic acid ammonium salt<\/p>\n<\/td>\n

\n

540-69-2<\/p>\n<\/td>\n

\n

2915.12.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n<\/tr>\n

\n

31<\/p>\n<\/td>\n

\n

Diethylamine<\/p>\n<\/td>\n

\n

N<\/i>-ethylethanamine<\/p>\n<\/td>\n

\n

109-89-7<\/p>\n<\/td>\n

\n

2921.19.50<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n<\/tr>\n

\n

32<\/p>\n<\/td>\n

\n

Ethyl ether<\/p>\n<\/td>\n

\n

1-1\u2019-oxybis[ethane]<\/p>\n<\/td>\n

\n

60-29-7<\/p>\n<\/td>\n

\n

2909.11.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n<\/tr>\n

\n

33<\/p>\n<\/td>\n

\n

Ethylene diacetate<\/p>\n<\/td>\n

\n

1,2-ethanediol diacetate<\/p>\n<\/td>\n

\n

111-55-7<\/p>\n<\/td>\n

\n

2915.39.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n<\/tr>\n

\n

34<\/p>\n<\/td>\n

\n

Formamide<\/p>\n<\/td>\n

\n

Methanamide<\/p>\n<\/td>\n

\n

75-12-7<\/p>\n<\/td>\n

\n

2924.19.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n<\/tr>\n

\n

35<\/p>\n<\/td>\n

\n

Formic Acid<\/p>\n<\/td>\n

\n

Methamoic Acid<\/p>\n<\/td>\n

\n

64-18-6<\/p>\n<\/td>\n

\n

2915.11.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n<\/tr>\n

\n

36<\/p>\n<\/td>\n

\n

Hydrochloric acid<\/p>\n<\/td>\n

\n

Hydrochloric acid<\/p>\n<\/td>\n

\n

7647-01-0<\/p>\n<\/td>\n

\n

2806.10.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n<\/tr>\n

\n

37<\/p>\n<\/td>\n

\n

Methyl ethyl ketone<\/p>\n<\/td>\n

\n

2-Butanone<\/p>\n<\/td>\n

\n

78-93-3<\/p>\n<\/td>\n

\n

2914.12.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n<\/tr>\n

\n

38<\/p>\n<\/td>\n

\n

Methylamine<\/p>\n<\/td>\n

\n

Methanamine<\/p>\n<\/td>\n

\n

74-89-5<\/p>\n<\/td>\n

\n

2921.11.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n<\/tr>\n

\n

39<\/p>\n<\/td>\n

\n

Nitroethane<\/p>\n<\/td>\n

\n

\u00a0Nitroethane<\/p>\n<\/td>\n

\n

79-24-3<\/p>\n<\/td>\n

\n

2904.20.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n<\/tr>\n

\n

40<\/p>\n<\/td>\n

\n

Potassium permanganate<\/p>\n<\/td>\n

\n

\u00a0Potassium permanganate<\/p>\n<\/td>\n

\n

7722-64-7<\/p>\n<\/td>\n

\n

2841.61.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n<\/tr>\n

\n

41<\/p>\n<\/td>\n

\n

Sulfuric acid<\/p>\n<\/td>\n

\n

Sulfuric acid<\/p>\n<\/td>\n

\n

7664-93-9<\/p>\n<\/td>\n

\n

2807.00.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n<\/tr>\n

\n

42<\/p>\n<\/td>\n

\n

Tartaric acid<\/p>\n<\/td>\n

\n

2,3-Dihydroxy butanedioic acid<\/p>\n<\/td>\n

\n

526-83-0<\/p>\n<\/td>\n

\n

2918.12.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n<\/tr>\n

\n

43<\/p>\n<\/td>\n

\n

Thionyl chloride<\/p>\n<\/td>\n

\n

Thionyl chloride<\/p>\n<\/td>\n

\n

7719-09-7<\/p>\n<\/td>\n

\n

2812.10.95<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n<\/tr>\n

\n

44<\/p>\n<\/td>\n

\n

Toluene<\/p>\n<\/td>\n

\n

Methyl benzene<\/p>\n<\/td>\n

\n

108-88-3<\/p>\n<\/td>\n

\n

2902.30.00<\/p>\n<\/td>\n

\n

B\u1ed9 C\u00f4ng Th\u01b0\u01a1ng<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00bb Lu\u1eadt s\u01b0 chuy\u00ean t\u01b0 v\u1ea5n, b\u00e0o ch\u1eefa t\u1ed9i ma t\u00fay<\/a><\/p>\n

\u00bb Lu\u1eadt s\u01b0 b\u00e0o ch\u1eefa v\u1ee5 \u00e1n ma t\u00fay<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Ngh\u1ecb \u0111\u1ecbnh 73\/2018\/N\u0110-CP quy \u0111\u1ecbnh v\u1ec1 danh m\u1ee5c ch\u1ea5t ma t\u00fay v\u00e0 ti\u1ec1n ch\u1ea5t ma t\u00fay CH\u00cdNH PH\u1ee6 C\u1ed8NG H\u00d2A X\u00c3 H\u1ed8I CH\u1ee6 NGH\u0128A VI\u1ec6T NAM \u0110\u1ed9c l\u1eadp \u2013 T\u1ef1 do \u2013 H\u1ea1nh ph\u00fac\u00a0 S\u1ed1: 73\/2018\/N\u0110-CP H\u00e0 N\u1ed9i, ng\u00e0y 15 th\u00e1ng 5 n\u0103m 2018 \u0110\u00e3 c\u00f3 \u00bb Ngh\u1ecb \u0111\u1ecbnh s\u1ed1\u00a057\/2022\/N\u0110-CP\u00a0Quy \u0111\u1ecbnh c\u00e1c danh m\u1ee5c ch\u1ea5t […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[162],"tags":[],"_links":{"self":[{"href":"https:\/\/luatsubaoho.com\/phapluat\/wp-json\/wp\/v2\/posts\/12078"}],"collection":[{"href":"https:\/\/luatsubaoho.com\/phapluat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/luatsubaoho.com\/phapluat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/luatsubaoho.com\/phapluat\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/luatsubaoho.com\/phapluat\/wp-json\/wp\/v2\/comments?post=12078"}],"version-history":[{"count":3,"href":"https:\/\/luatsubaoho.com\/phapluat\/wp-json\/wp\/v2\/posts\/12078\/revisions"}],"predecessor-version":[{"id":41646,"href":"https:\/\/luatsubaoho.com\/phapluat\/wp-json\/wp\/v2\/posts\/12078\/revisions\/41646"}],"wp:attachment":[{"href":"https:\/\/luatsubaoho.com\/phapluat\/wp-json\/wp\/v2\/media?parent=12078"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/luatsubaoho.com\/phapluat\/wp-json\/wp\/v2\/categories?post=12078"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/luatsubaoho.com\/phapluat\/wp-json\/wp\/v2\/tags?post=12078"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}